Background	Background	NNP	0
Antigenic	Antigenic	NNP	B-NP
drift	drift	NN	I-NP
and	and	CC	0
the	the	DT	0
generation	generation	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
quasispecy	quasispecy	NN	I-NP
Some	Some	DT	0
rna	rna	NN	B-NP
virus	virus	NN	I-NP
form	form	VBP	0
a	a	DT	0
quasispecies--a	quasispecies--a	JJ	B-NP
set	set	NN	I-NP
of	of	IN	0
related	related	JJ	0
viral	viral	JJ	B-NP
variant	variant	JJ	I-NP
that	that	IN	0
coexist	coexist	NN	0
in	in	IN	0
field	field	NN	0
populations	populations	NNS	0
and	and	CC	0
even	even	RB	0
within	within	IN	0
single	single	JJ	0
infected	infected	JJ	0
individuals	individuals	NNS	0
(	(	-LRB-	0
reviewed	reviewed	VBN	0
in	in	IN	0
[	[	-LRB-	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
emergence	emergence	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
quasispecy	quasispecy	NN	I-NP
immunologically	immunologically	JJ	I-NP
distinct	distinct	JJ	I-NP
member	member	NN	I-NP
through	through	IN	0
mutation	mutation	NN	0
and	and	CC	0
subsequent	subsequent	JJ	0
immune	immune	JJ	0
selection	selection	NN	0
is	is	VBZ	0
called	called	VBN	0
"antigenic	"antigenic	CD	0
drift	drift	NN	0
.	.	.	0
"	"	''	0
Antigenic	Antigenic	JJ	B-NP
drift	drift	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
important	important	JJ	0
in	in	IN	0
human	human	JJ	B-NP
immunodeficiency	immunodeficiency	JJ	I-NP
virus	virus	NN	I-NP
(	(	-LRB-	0
HIV	HIV	NNP	B-NP
)	)	-RRB-	0
infection	infection	NN	B-NP
and	and	CC	0
the	the	DT	0
continuing	continuing	VBG	0
seasonal	seasonal	JJ	B-NP
influenza	influenza	JJ	I-NP
epidemic	epidemic	JJ	I-NP
because	because	IN	0
immunity	immunity	NN	0
generated	generated	VBD	0
against	against	IN	0
one	one	CD	0
viral	viral	JJ	B-NP
quasispecies	quasispecies	JJ	I-NP
member	member	NN	I-NP
selects	selects	NN	0
for	for	IN	0
escape	escape	JJ	B-NP
variant	variant	JJ	I-NP
.	.	.	0
Attributed	Attributed	VBN	0
in	in	IN	0
part	part	NN	0
to	to	TO	0
antigenic	antigenic	VB	0
drift	drift	NNS	0
are	are	VBP	0
the	the	DT	0
moderately	moderately	RB	0
high	high	JJ	0
failure	failure	NN	B-NP
rate	rate	NN	I-NP
and	and	CC	0
the	the	DT	0
short-lived	short-lived	JJ	0
efficacy	efficacy	NN	0
of	of	IN	0
influenza	influenza	JJ	B-NP
vaccine	vaccine	NN	I-NP
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
,	,	,	0
the	the	DT	0
failure	failure	NN	0
of	of	IN	0
synthetic	synthetic	JJ	B-NP
foot-and-mouth	foot-and-mouth	JJ	I-NP
disease	disease	NN	I-NP
virus	virus	NN	I-NP
vaccine	vaccine	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
the	the	DT	0
inability	inability	NN	0
of	of	IN	0
recombinant	recombinant	JJ	0
hiv	hiv	NN	B-NP
vaccine	vaccine	NN	I-NP
to	to	TO	0
provide	provide	VB	0
complete	complete	JJ	0
protection	protection	NN	0
against	against	IN	0
field	field	NN	0
strains	strains	NNS	0
of	of	IN	0
the	the	DT	0
virus	virus	NN	0
[	[	-LRB-	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
hemagglutinin	hemagglutinin	NN	B-NP
(	(	-LRB-	0
HA	HA	NNP	B-NP
)	)	-RRB-	0
envelope	envelope	NN	B-NP
surface	surface	NN	I-NP
glycoprotein--the	glycoprotein--the	JJ	I-NP
major	major	JJ	0
neutralizing	neutralizing	JJ	0
influenza	influenza	JJ	B-NP
a--i	a--i	NN	I-NP
determinant	determinant	NN	I-NP
a	a	DT	0
classic	classic	JJ	B-NP
example	example	NN	I-NP
of	of	IN	0
an	an	DT	0
antigenically	antigenically	JJ	B-NP
drifting	drifting	JJ	I-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
Walter	Walter	NNP	0
Gerhard	Gerhard	NNP	0
and	and	CC	0
colleagues	colleagues	NNS	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
the	the	DT	0
immune	immune	JJ	0
pressure	pressure	NN	B-NP
exerted	exerted	NN	I-NP
by	by	IN	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
Abs	Abs	NNP	B-NP
)	)	-RRB-	0
selects	selects	VBZ	0
for	for	IN	0
ha	ha	NNP	B-NP
escape	escape	NN	I-NP
mutant	mutant	NN	I-NP
in	in	IN	0
model	model	NN	B-NP
system	system	NN	I-NP
[	[	-LRB-	0
10	10	CD	0
,	,	,	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
Later	Later	RB	0
,	,	,	0
Dimmock	Dimmock	NNP	B-NP
and	and	CC	0
colleagues	colleagues	NNS	0
showed	showed	VBD	0
that	that	DT	0
polyclonal	polyclonal	JJ	B-NP
anti-sera	anti-sera	NN	I-NP
also	also	RB	0
select	select	VB	0
for	for	IN	0
escape	escape	JJ	B-NP
mutant	mutant	NN	I-NP
[	[	-LRB-	0
12	12	CD	0
,	,	,	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
much	much	RB	0
of	of	IN	0
the	the	DT	0
observed	observed	JJ	0
variability	variability	NN	0
of	of	IN	0
glycoprotein	glycoprotein	CD	B-NP
120	120	CD	0
(	(	-LRB-	0
gp120	gp120	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
the	the	DT	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
principal	principal	JJ	I-NP
surface	surface	NN	I-NP
antigen	antigen	NN	I-NP
,	,	,	0
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
reflect	reflect	VB	0
antigenic	antigenic	JJ	B-NP
drift	drift	NN	I-NP
[	[	-LRB-	0
14	14	CD	0
,	,	,	0
15	15	CD	0
,	,	,	0
16	16	CD	0
,	,	,	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
correlation	correlation	NN	0
of	of	IN	0
intra-patient	intra-patient	JJ	B-NP
viral	viral	JJ	I-NP
diversity	diversity	NN	I-NP
with	with	IN	0
immune	immune	JJ	0
response	response	NN	B-NP
strength	strength	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
cited	cited	VBN	0
as	as	IN	0
evidence	evidence	NN	0
that	that	IN	0
the	the	DT	0
immune	immune	JJ	0
response	response	NN	0
is	is	VBZ	0
a	a	DT	0
selective	selective	JJ	B-NP
factor	factor	NN	I-NP
in	in	IN	0
HIV	HIV	NNP	B-NP
antigenic	antigenic	NN	I-NP
drift	drift	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
,	,	,	0
19	19	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
21	21	CD	0
,	,	,	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
phylogenetic	phylogenetic	NN	B-NP
analysis	analysis	NN	I-NP
describe	describe	VBP	0
divergence	divergence	VBN	0
within	within	IN	0
a	a	DT	0
viral	viral	JJ	B-NP
population	population	NN	I-NP
,	,	,	0
and	and	CC	0
these	these	DT	0
methods	methods	NNS	0
have	have	VBP	0
been	been	VBN	0
used	used	VBN	0
to	to	TO	0
infer	infer	VB	0
the	the	DT	0
viral	viral	JJ	B-NP
variation	variation	NN	I-NP
selective	selective	JJ	I-NP
advantage	advantage	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
,	,	,	0
19	19	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
21	21	CD	0
,	,	,	0
22	22	CD	0
,	,	,	0
23	23	CD	0
,	,	,	0
24	24	CD	0
,	,	,	0
25	25	CD	0
,	,	,	0
26	26	CD	0
,	,	,	0
27	27	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
,	,	,	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
more	more	RBR	0
direct	direct	JJ	0
indication	indication	NN	0
of	of	IN	0
the	the	DT	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
gained	gained	VBD	0
through	through	IN	0
variation	variation	NN	0
is	is	VBZ	0
an	an	DT	0
observed	observed	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
overabundance	overabundance	NN	I-NP
relative	relative	JJ	0
to	to	TO	0
silent	silent	JJ	0
mutations	mutations	NNS	0
in	in	IN	0
viral	viral	JJ	B-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Such	Such	JJ	0
analyses	analyses	NNS	0
of	of	IN	0
gp120	gp120	NNP	B-NP
and	and	CC	0
its	its	PRP$	0
V	V	NNP	0
regions	regions	NNS	0
indicate	indicate	VBP	0
that	that	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
generally	generally	RB	0
over-represented	over-represented	JJ	0
in	in	IN	0
this	this	DT	0
protein	protein	NN	B-NP
and	and	CC	0
thus	thus	RB	0
appear	appear	VB	0
to	to	TO	0
confer	confer	VB	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
to	to	TO	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
,	,	,	0
24	24	CD	0
,	,	,	0
25	25	CD	0
,	,	,	0
26	26	CD	0
,	,	,	0
27	27	CD	0
,	,	,	0
28	28	CD	0
,	,	,	0
29	29	CD	0
,	,	,	0
30	30	CD	0
,	,	,	0
32	32	CD	0
,	,	,	0
33	33	CD	0
,	,	,	0
34	34	CD	0
,	,	,	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
more	more	RBR	0
detailed	detailed	JJ	0
analyses	analyses	NNS	0
,	,	,	0
several	several	JJ	0
groups	groups	NNS	0
tested	tested	VBD	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
individual	individual	JJ	I-NP
codon	codon	NN	I-NP
that	that	WDT	0
are	are	VBP	0
,	,	,	0
as	as	IN	0
an	an	DT	0
aggregate	aggregate	NN	B-NP
,	,	,	0
overabundant	overabundant	NNS	0
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
36	36	CD	0
,	,	,	0
37	37	CD	0
,	,	,	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
none	none	NN	0
of	of	IN	0
these	these	DT	0
methods	methods	NNS	0
determine	determine	VBP	0
which	which	WDT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
actually	actually	RB	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
when	when	WRB	0
varying	varying	VBG	B-NP
fitness	fitness	NNS	I-NP
replacement	replacement	NN	I-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
lumped	lumped	VBN	0
together	together	RB	0
,	,	,	0
positively	positively	RB	0
selected	selected	VBN	B-NP
mutation	mutation	NN	I-NP
may	may	MD	0
remain	remain	VB	0
undetected	undetected	VBN	0
among	among	IN	0
negatively	negatively	RB	0
selected	selected	VBN	B-NP
mutation	mutation	NN	I-NP
.	.	.	0
To	To	TO	0
overcome	overcome	VB	0
these	these	DT	0
limitations	limitations	NNS	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
developed	developed	VBN	0
a	a	DT	0
"selection	"selection	JJ	0
mapping	mapping	NN	0
"	"	''	0
algorithm	algorithm	NN	B-NP
.	.	.	0
The	The	DT	0
cornerstone	cornerstone	NN	0
of	of	IN	0
selection	selection	NN	B-NP
mapping	mapping	NN	I-NP
is	is	VBZ	0
the	the	DT	0
testing	testing	NN	0
of	of	IN	0
each	each	DT	0
observed	observed	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
at	at	IN	0
each	each	DT	0
codon	codon	NN	B-NP
to	to	TO	0
identify	identify	VB	0
those	those	DT	0
particular	particular	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
that	that	WDT	0
are	are	VBP	0
overabundant	overabundant	JJ	0
relative	relative	JJ	0
to	to	TO	0
silent	silent	JJ	0
mutations	mutations	NNS	0
at	at	IN	0
that	that	DT	0
codon	codon	NN	B-NP
.	.	.	0
Such	Such	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
determined	determined	VBN	0
to	to	TO	0
be	be	VB	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
Negatively	Negatively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
recognized	recognized	VBN	0
as	as	IN	0
"noise	"noise	NNP	0
"	"	''	0
and	and	CC	0
are	are	VBP	0
thereafter	thereafter	RB	0
ignored	ignored	VBN	0
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
use	use	VBP	0
the	the	DT	0
selection	selection	NN	B-NP
mapping	mapping	NN	I-NP
method	method	NN	I-NP
to	to	TO	0
identify	identify	VB	0
the	the	DT	0
positively	positively	RB	0
influenza	influenza	VBG	B-NP
selected	selected	VBN	I-NP
variant	variant	JJ	I-NP
A	A	DT	0
hemagglutinin	hemagglutinin	NN	B-NP
(	(	-LRB-	0
H3	H3	NN	B-NP
serotype	serotype	NN	I-NP
)	)	-RRB-	0
,	,	,	0
HIV-1	HIV-1	NNP	B-NP
reverse	reverse	JJ	I-NP
transcriptase	transcriptase	NN	I-NP
(	(	-LRB-	0
RT	RT	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
HIV-1	HIV-1	NNP	B-NP
gp120	gp120	NNP	I-NP
.	.	.	0
Results	Results	NNS	0
and	and	CC	0
Discussion	Discussion	NNP	0
influenza	influenza	VBG	B-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
A	A	DT	0
H3	H3	NN	B-NP
hemagglutinin	hemagglutinin	NN	I-NP
QUASI	QUASI	NN	I-NP
identifies	identifies	VBZ	0
25	25	CD	0
ha	ha	NNP	B-NP
codon	codon	NN	I-NP
where	where	WRB	0
one	one	PRP	0
or	or	CC	0
more	more	JJR	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
in	in	IN	0
the	the	DT	0
influenza	influenza	NN	B-NP
A	A	DT	0
H3	H3	JJ	B-NP
virus	virus	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
[	[	-LRB-	0
From	From	IN	0
our	our	PRP$	0
quasi	quasi	NN	B-NP
neutral	neutral	JJ	I-NP
drift	drift	NN	I-NP
testing	testing	NN	I-NP
,	,	,	0
we	we	PRP	0
expect	expect	VBP	0
a	a	DT	0
maximum	maximum	NN	B-NP
of	of	IN	0
about	about	IN	0
2-3	2-3	CD	0
false	false	JJ	0
positives	positives	NNS	0
(	(	-LRB-	0
see	see	VB	0
Materials	Materials	NNPS	0
and	and	CC	0
Methods	Methods	NNP	0
)	)	-RRB-	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
distribution	distribution	NN	B-NP
of	of	IN	0
these	these	DT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
codon	codon	NN	I-NP
is	is	VBZ	0
of	of	IN	0
particular	particular	JJ	0
interest	interest	NN	0
.	.	.	0
Without	Without	IN	0
exception	exception	NN	0
,	,	,	0
the	the	DT	0
codon	codon	NN	B-NP
where	where	WRB	0
variants	variants	NNS	0
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
are	are	VBP	0
on	on	IN	0
the	the	DT	0
HA	HA	NNP	B-NP
surface	surface	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2	2	CD	0
,	,	,	0
left	left	VBN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
parsimonious	parsimonious	JJ	B-NP
explanation	explanation	NN	I-NP
of	of	IN	0
this	this	DT	0
result	result	NN	0
is	is	VBZ	0
that	that	IN	0
ha	ha	NNP	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
primarily	primarily	RB	0
selected	selected	VBN	0
for	for	IN	0
escape	escape	NN	0
from	from	IN	0
B-cell	B-cell	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
If	If	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
is	is	VBZ	0
instead	instead	RB	0
the	the	DT	0
affecting	affecting	VBG	B-NP
ha	ha	NNP	I-NP
variation	variation	NN	I-NP
primary	primary	JJ	I-NP
selective	selective	JJ	I-NP
force	force	NN	I-NP
,	,	,	0
then	then	RB	0
either	either	RB	0
all	all	DT	0
t-cell	t-cell	NN	B-NP
immunity	immunity	NN	I-NP
escape	escape	NN	I-NP
variant	variant	JJ	I-NP
are	are	VBP	0
coincidentally	coincidentally	JJ	0
solvent-exposed	solvent-exposed	NN	0
,	,	,	0
or	or	CC	0
ha	ha	NNP	B-NP
t-cell	t-cell	NN	I-NP
epitope	epitope	NN	I-NP
are	are	VBP	0
determined	determined	VBN	0
by	by	IN	0
Ab	Ab	NNP	B-NP
protection	protection	NN	I-NP
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
25	25	CD	0
codon	codon	NN	B-NP
include	include	VBP	0
13	13	CD	0
outside	outside	IN	0
those	those	DT	0
identified	identified	VBN	0
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
by	by	IN	0
Walter	Walter	NNP	0
Fitch	Fitch	NNP	0
and	and	CC	0
colleagues	colleagues	NNS	0
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
attribute	attribute	VBP	0
our	our	PRP$	0
new	new	JJ	0
findings	findings	NNS	0
primarily	primarily	RB	0
to	to	TO	0
sites	sites	VB	0
where	where	WRB	0
many	many	JJ	0
variants	variants	NNS	0
are	are	VBP	0
negatively	negatively	RB	0
selected	selected	VBN	0
but	but	CC	0
where	where	WRB	0
at	at	IN	0
least	least	JJS	0
one	one	CD	0
variant	variant	NN	0
is	is	VBZ	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
The	The	DT	0
Fitch	Fitch	NNP	B-NP
group	group	NN	I-NP
also	also	RB	0
identifies	identifies	VBZ	0
6	6	CD	0
additional	additional	JJ	0
codon	codon	NN	B-NP
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
We	We	PRP	0
believe	believe	VBP	0
that	that	IN	0
these	these	DT	0
are	are	VBP	0
false	false	JJ	0
positives	positives	NNS	0
caused	caused	VBN	0
by	by	IN	0
the	the	DT	0
Fitch	Fitch	NNP	B-NP
group	group	NN	I-NP
's	's	POS	0
assumption	assumption	NN	0
that	that	IN	0
hemagglutinin	hemagglutinin	NN	B-NP
is	is	VBZ	0
,	,	,	0
on	on	IN	0
average	average	NN	0
,	,	,	0
neutrally	neutrally	JJ	B-NP
drifting	drifting	NN	I-NP
;	;	:	0
these	these	DT	0
six	six	CD	0
codon	codon	NN	B-NP
may	may	MD	0
be	be	VB	0
less	less	RBR	0
negatively	negatively	RB	0
selected	selected	VBN	0
than	than	IN	0
average	average	NN	0
,	,	,	0
but	but	CC	0
they	they	PRP	0
nevertheless	nevertheless	RB	0
appear	appear	VB	0
to	to	TO	0
be	be	VB	0
negatively	negatively	RB	0
selected	selected	VBN	0
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
our	our	PRP$	0
data	data	NNS	0
,	,	,	0
while	while	IN	0
largely	largely	RB	0
the	the	DT	0
same	same	JJ	0
as	as	IN	0
those	those	DT	0
analyzed	analyzed	NN	0
by	by	IN	0
the	the	DT	0
Fitch	Fitch	NNP	B-NP
group	group	NN	I-NP
,	,	,	0
do	do	VBP	0
have	have	VB	0
some	some	DT	0
differences	differences	NNS	0
.	.	.	0
Wiley	Wiley	FW	0
et	et	FW	0
al	al	FW	0
.	.	.	0
proposed	proposed	VBD	0
four	four	CD	0
antigenic	antigenic	CD	B-NP
site	site	NN	I-NP
where	where	WRB	0
field	field	NN	0
and	and	CC	0
laboratory	laboratory	NN	B-NP
mutation	mutation	NN	I-NP
could	could	MD	0
be	be	VB	0
grouped	grouped	VBN	0
on	on	IN	0
the	the	DT	0
HA	HA	NNP	B-NP
surface	surface	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
putative	putative	JJ	B-NP
antigenic	antigenic	JJ	I-NP
site	site	NN	I-NP
are	are	VBP	0
indicated	indicated	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
1and	1and	CD	0
the	the	DT	0
right	right	JJ	0
side	side	NN	0
of	of	IN	0
Figure	Figure	NNP	0
2	2	CD	0
.	.	.	0
Positively	Positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
correlated	correlated	NNS	0
(	(	-LRB-	0
Fisher	Fisher	NNP	0
's	's	POS	0
exact	exact	JJ	0
test	test	NN	0
)	)	-RRB-	0
with	with	IN	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
A	A	DT	0
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
5.27	5.27	CD	0
×	×	CD	0
10	10	CD	0
-3	-3	CD	0
)	)	-RRB-	0
,	,	,	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
B	B	NNP	I-NP
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
1.12	1.12	CD	0
×	×	CD	0
10	10	CD	0
-3	-3	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
C	C	NNP	I-NP
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
1.0	1.0	CD	0
×	×	CD	0
10	10	CD	0
-5	-5	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
D	D	NNP	I-NP
is	is	VBZ	0
not	not	RB	0
particularly	particularly	RB	0
correlated	correlated	VBN	0
with	with	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
.	.	.	0
We	We	PRP	0
believe	believe	VBP	0
the	the	DT	0
lack	lack	NN	0
of	of	IN	0
positively	positively	FW	0
spanning	spanning	VBG	B-NP
antigenic	antigenic	NN	I-NP
site	site	NN	I-NP
d	d	NN	I-NP
selected	selected	VBN	I-NP
variant	variant	JJ	I-NP
may	may	MD	0
explain	explain	VB	0
a	a	DT	0
decades-old	decades-old	JJ	B-NP
puzzle	puzzle	NN	I-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
fully	fully	RB	0
assembled	assembled	VBN	B-NP
HA	HA	NNP	I-NP
protein	protein	NN	I-NP
,	,	,	0
site	site	NN	0
D	D	NNP	0
is	is	VBZ	0
buried	buried	VBN	0
in	in	IN	0
the	the	DT	0
trimer	trimer	JJ	B-NP
interface	interface	NN	I-NP
and	and	CC	0
therefore	therefore	RB	0
is	is	VBZ	0
not	not	RB	0
generally	generally	RB	0
accessible	accessible	JJ	0
to	to	TO	0
Ab	Ab	NNP	B-NP
[	[	-LRB-	0
41	41	CD	0
,	,	,	0
42	42	CD	0
]	]	-RRB-	0
.	.	.	0
At	At	IN	0
the	the	DT	0
time	time	NN	0
that	that	IN	0
the	the	DT	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
were	were	VBD	0
proposed	proposed	VBN	0
,	,	,	0
residues	residues	NNS	0
in	in	IN	0
and	and	CC	0
around	around	IN	0
the	the	DT	0
trimer	trimer	JJ	B-NP
interface	interface	NN	I-NP
were	were	VBD	0
variable	variable	JJ	0
and	and	CC	0
found	found	VBD	0
on	on	IN	0
the	the	DT	0
monomer	monomer	JJ	0
surface	surface	NN	0
,	,	,	0
so	so	RB	0
they	they	PRP	0
were	were	VBD	0
grouped	grouped	VBN	0
and	and	CC	0
labeled	labeled	VBN	0
as	as	IN	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
D	D	NNP	I-NP
even	even	RB	0
though	though	IN	0
it	it	PRP	0
was	was	VBD	0
unclear	unclear	JJ	0
how	how	WRB	0
site	site	NN	0
D	D	NNP	0
was	was	VBD	0
recognized	recognized	VBN	0
by	by	IN	0
Ab	Ab	NNP	B-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
fact	fact	NN	0
,	,	,	0
the	the	DT	0
only	only	RB	0
two	two	CD	0
positively	positively	RB	0
quasi	quasi	NN	B-NP
selected	selected	VBN	I-NP
variant	variant	JJ	I-NP
identifies	identifies	VBZ	0
in	in	IN	0
site	site	NN	0
D	D	NNP	0
are	are	VBP	0
solvent-exposed	solvent-exposed	JJ	0
at	at	IN	0
the	the	DT	0
extreme	extreme	JJ	0
edge	edge	NN	0
of	of	IN	0
the	the	DT	0
HA	HA	NNP	B-NP
trimer	trimer	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
QUASI	QUASI	NNP	0
's	's	POS	0
hemagglutinin	hemagglutinin	NN	B-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
,	,	,	0
we	we	PRP	0
now	now	RB	0
conclude	conclude	VB	0
that	that	IN	0
those	those	DT	0
mutations	mutations	NN	0
found	found	VBD	0
in	in	IN	0
the	the	DT	0
hemagglutinin	hemagglutinin	NN	B-NP
trimer-buried	trimer-buried	JJ	I-NP
portion	portion	NN	I-NP
do	do	VBP	0
not	not	RB	0
confer	confer	VB	0
significant	significant	JJ	0
advantage	advantage	NN	0
on	on	IN	0
influenza	influenza	JJ	B-NP
A.	A.	NN	0
That	That	WDT	0
is	is	VBZ	0
,	,	,	0
while	while	IN	0
the	the	DT	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
d	d	NN	I-NP
trimer-buried	trimer-buried	JJ	I-NP
portion	portion	NN	I-NP
includes	includes	VBZ	0
the	the	DT	0
sound	sound	NN	0
and	and	CC	0
fury	fury	NN	0
of	of	IN	0
variability	variability	NN	0
,	,	,	0
it	it	PRP	0
signifies	signifies	JJ	0
nothing	nothing	NN	0
.	.	.	0
While	While	IN	0
QUASI	QUASI	NNP	B-NP
finds	finds	VBZ	0
that	that	DT	0
a-c	a-c	NN	B-NP
antigenic	antigenic	JJ	I-NP
site	site	NN	I-NP
are	are	VBP	0
significantly	significantly	RB	0
associated	associated	VBN	0
with	with	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variation	variation	NN	I-NP
,	,	,	0
this	this	DT	0
association	association	NN	0
may	may	MD	0
be	be	VB	0
a	a	DT	0
simple	simple	JJ	0
consequence	consequence	NN	0
of	of	IN	0
the	the	DT	0
sites	sites	NNS	0
'	'	POS	0
surface	surface	NN	0
exposure	exposure	NN	0
.	.	.	0
As	As	RB	0
can	can	MD	0
be	be	VB	0
seen	seen	VBN	0
in	in	IN	0
the	the	DT	0
left-hand	left-hand	JJ	0
side	side	NN	0
of	of	IN	0
Figure	Figure	NNP	0
2	2	CD	0
,	,	,	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
scattered	scattered	VBN	0
across	across	IN	0
the	the	DT	0
entire	entire	JJ	0
exposed	exposed	JJ	0
surface	surface	NN	0
of	of	IN	0
hemagglutinin	hemagglutinin	NN	B-NP
.	.	.	0
There	There	EX	0
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
outside	outside	IN	0
the	the	DT	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
,	,	,	0
and	and	CC	0
there	there	EX	0
are	are	VBP	0
subregions	subregions	VBN	0
of	of	IN	0
the	the	DT	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
where	where	WRB	0
variation	variation	NN	0
is	is	VBZ	0
negatively	negatively	RB	0
selected	selected	VBN	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
it	it	PRP	0
may	may	MD	0
be	be	VB	0
more	more	RBR	0
appropriate	appropriate	JJ	0
to	to	TO	0
view	view	VB	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
as	as	IN	0
more	more	JJR	0
positional	positional	NN	B-NP
than	than	IN	0
functional	functional	NN	0
.	.	.	0
Indeed	Indeed	RB	0
,	,	,	0
more	more	RBR	0
recent	recent	JJ	0
antigenic	antigenic	NN	B-NP
site	site	NN	I-NP
demarcation	demarcation	NN	I-NP
enlarge	enlarge	FW	0
a-d	a-d	NN	B-NP
antigenic	antigenic	NN	I-NP
site	site	NN	I-NP
and	and	CC	0
add	add	VB	0
an	an	DT	0
additional	additional	JJ	0
antigenic	antigenic	JJ	B-NP
site	site	NN	I-NP
,	,	,	0
site	site	NN	B-NP
E	E	NN	I-NP
,	,	,	0
and	and	CC	0
these	these	DT	0
sites	sites	NNS	0
are	are	VBP	0
now	now	RB	0
considered	considered	VBN	0
primarily	primarily	RB	0
positional	positional	VBN	0
rather	rather	RB	0
than	than	IN	0
functional	functional	NNS	0
[	[	-LRB-	0
6	6	CD	0
,	,	,	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
hiv-1	hiv-1	NN	B-NP
gp120	gp120	NNP	I-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
At	At	IN	0
123	123	CD	0
codon	codon	NN	B-NP
,	,	,	0
QUASI	QUASI	NNP	0
's	's	POS	0
gp120	gp120	NNP	B-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
indicates	indicates	VBZ	0
that	that	IN	0
one	one	CD	0
or	or	CC	0
more	more	RBR	0
non-consensus	non-consensus	JJ	B-NP
amino	amino	JJ	0
acids	acids	NNS	0
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
in	in	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
Most	Most	RBS	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
appear	appear	VBP	0
to	to	TO	0
be	be	VB	0
on	on	IN	0
the	the	DT	0
gp120	gp120	JJ	B-NP
surface	surface	NN	I-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
,	,	,	0
but	but	CC	0
in	in	IN	0
contrast	contrast	NN	0
to	to	TO	0
hemagglutinin	hemagglutinin	NN	B-NP
,	,	,	0
gp120	gp120	NNP	B-NP
includes	includes	VBZ	0
several	several	JJ	0
monomer-buried	monomer-buried	NN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
(	(	-LRB-	0
at	at	IN	0
sites	sites	CD	0
I225	I225	CD	B-NP
,	,	,	0
V270	V270	NNP	B-NP
,	,	,	0
N295	N295	NNP	B-NP
,	,	,	0
H333	H333	NNP	B-NP
,	,	,	0
I345	I345	NNP	B-NP
,	,	,	0
T387	T387	NNP	B-NP
,	,	,	0
I424	I424	NNP	B-NP
,	,	,	0
and	and	CC	0
L453	L453	CD	B-NP
)	)	-RRB-	0
.	.	.	0
Additionally	Additionally	RB	0
,	,	,	0
some	some	DT	0
of	of	IN	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
that	that	WDT	0
appear	appear	VBP	0
to	to	TO	0
be	be	VB	0
solvent-exposed	solvent-exposed	NN	0
may	may	MD	0
normally	normally	RB	0
be	be	VB	0
buried	buried	VBN	0
(	(	-LRB-	0
some	some	DT	0
loops	loops	NNS	0
are	are	VBP	0
absent	absent	VBN	0
from	from	IN	0
the	the	DT	0
core	core	NN	0
protein	protein	NN	0
crystal	crystal	NN	0
structure	structure	NN	0
[	[	-LRB-	0
44	44	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
burial	burial	NN	0
of	of	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
in	in	IN	0
the	the	DT	0
gp120	gp120	JJ	B-NP
monomer	monomer	NN	I-NP
confirms	confirms	VBZ	0
that	that	IN	0
gp120	gp120	CD	B-NP
quasispeciation	quasispeciation	NN	I-NP
is	is	VBZ	0
not	not	RB	0
selected	selected	VBN	0
solely	solely	RB	0
for	for	IN	0
escape	escape	NN	0
from	from	IN	0
B-cell	B-cell	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
Two	Two	CD	0
competition-group	competition-group	JJ	B-NP
epitope	epitope	NN	I-NP
have	have	VBP	0
been	been	VBN	0
identified	identified	VBN	0
for	for	IN	0
broadly	broadly	RB	0
neutralizing	neutralizing	JJ	0
anti-gp120	anti-gp120	NNP	B-NP
ab	ab	NN	I-NP
:	:	:	0
the	the	DT	0
CD4-binding	CD4-binding	JJ	B-NP
site	site	NN	I-NP
(	(	-LRB-	0
CD4BS	CD4BS	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
the	the	DT	0
CD4-induced	CD4-induced	NNP	B-NP
(	(	-LRB-	0
CD4i	CD4i	NNP	B-NP
)	)	-RRB-	0
epitope	epitope	NN	B-NP
(	(	-LRB-	0
references	references	NNS	0
in	in	IN	0
[	[	-LRB-	0
45	45	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
Each	Each	DT	0
epitope	epitope	NN	B-NP
includes	includes	VBZ	0
only	only	RB	0
a	a	DT	0
single	single	JJ	0
non-consensus	non-consensus	NN	B-NP
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
broadly	broadly	RB	0
neutralizing	neutralizing	JJ	0
antibody	antibody	NN	B-NP
appear	appear	VBP	0
to	to	TO	0
be	be	VB	0
those	those	DT	0
that	that	WDT	0
engage	engage	VBP	0
few	few	JJ	0
protein	protein	NN	B-NP
position	position	NN	I-NP
where	where	WRB	0
variation	variation	NN	0
is	is	VBZ	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
Based	Based	VBN	0
on	on	IN	0
this	this	DT	0
observation	observation	NN	0
,	,	,	0
we	we	PRP	0
propose	propose	VBP	0
that	that	IN	0
the	the	DT	0
neutralizing	neutralizing	JJ	0
spectra	spectra	NN	0
of	of	IN	0
antibody	antibody	NN	B-NP
may	may	MD	0
be	be	VB	0
predicted	predicted	VBN	0
if	if	IN	0
the	the	DT	0
epitope	epitope	NN	B-NP
are	are	VBP	0
known	known	VBN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
we	we	PRP	0
would	would	MD	0
predict	predict	VB	0
that	that	IN	0
the	the	DT	0
anti-CD4BS	anti-CD4BS	NNP	0
antibody	antibody	NN	B-NP
will	will	MD	0
have	have	VB	0
particular	particular	JJ	0
trouble	trouble	NN	0
recognizing	recognizing	VBG	B-NP
gp120	gp120	CD	I-NP
molecule	molecule	NN	I-NP
carrying	carrying	VBG	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	VBN	I-NP
of	of	IN	0
the	the	DT	0
CD4BS	CD4BS	CD	0
epitope	epitope	NNS	0
(	(	-LRB-	0
D→N	D→N	NNP	0
at	at	IN	0
codon	codon	CD	B-NP
474	474	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
prediction	prediction	NN	0
is	is	VBZ	0
fulfilled	fulfilled	VBN	0
in	in	IN	0
that	that	IN	0
the	the	DT	0
15e	15e	FW	0
anti-CD4BS	anti-CD4BS	FW	0
monoclonal	monoclonal	JJ	B-NP
Ab	Ab	NNP	I-NP
fails	fails	VBZ	0
to	to	TO	0
react	react	VB	0
to	to	TO	0
gp120	gp120	CD	B-NP
from	from	IN	0
HIV	HIV	NNP	B-NP
strain	strain	NN	I-NP
RF	RF	NNP	I-NP
,	,	,	0
a	a	DT	0
strain	strain	NN	0
that	that	WDT	0
carries	carries	VBZ	0
this	this	DT	0
D→N	D→N	JJ	0
mutation	mutation	NN	0
[	[	-LRB-	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
also	also	RB	0
predict	predict	VB	0
that	that	IN	0
gp120	gp120	CD	B-NP
molecule	molecule	NN	I-NP
carrying	carrying	VBG	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	0
I→F	I→F	CD	0
mutation	mutation	NN	0
at	at	IN	0
codon	codon	CD	B-NP
423	423	CD	0
will	will	MD	0
be	be	VB	0
poorly	poorly	RB	0
recognized	recognized	VBN	0
by	by	IN	0
the	the	DT	0
anti-CD4i	anti-CD4i	NNP	0
Abs	Abs	NNP	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
worth	worth	JJ	0
commenting	commenting	NN	0
on	on	IN	0
the	the	DT	0
GPGRAF	GPGRAF	NNP	B-NP
motif	motif	NN	I-NP
(	(	-LRB-	0
gp120	gp120	NN	B-NP
residue	residue	NN	I-NP
312-317	312-317	FW	0
)	)	-RRB-	0
that	that	WDT	0
is	is	VBZ	0
sometimes	sometimes	RB	0
(	(	-LRB-	0
though	though	RB	0
increasingly	increasingly	RB	0
rarely	rarely	RB	0
)	)	-RRB-	0
referred	referred	VBD	0
to	to	TO	0
as	as	RB	0
"highly	"highly	CD	0
conserved	conserved	NNS	0
.	.	.	0
"	"	''	0
Because	Because	IN	0
QUASI	QUASI	NNP	B-NP
identifies	identifies	VBZ	0
non-consensus	non-consensus	JJ	B-NP
variant	variant	JJ	I-NP
at	at	IN	0
two	two	CD	0
codon	codon	NN	B-NP
of	of	IN	0
this	this	DT	0
motif	motif	NN	B-NP
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
,	,	,	0
it	it	PRP	0
may	may	MD	0
be	be	VB	0
inappropriate	inappropriate	JJ	0
to	to	TO	0
refer	refer	VB	0
to	to	TO	0
the	the	DT	0
GPGRAF	GPGRAF	NNP	B-NP
motif	motif	NN	I-NP
as	as	IN	0
"highly	"highly	CD	0
conserved	conserved	NNS	0
.	.	.	0
"	"	''	0
Instead	Instead	RB	0
,	,	,	0
five	five	CD	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
appear	appear	VBP	0
to	to	TO	0
exist	exist	VB	0
at	at	IN	0
this	this	DT	0
region	region	NN	0
in	in	IN	0
addition	addition	NN	0
to	to	TO	0
GPGRAF	GPGRAF	NNP	B-NP
:	:	:	0
GPGKAF	GPGKAF	NNP	B-NP
,	,	,	0
GPGRTF	GPGRTF	NNP	B-NP
,	,	,	0
GPGKTF	GPGKTF	NNP	B-NP
,	,	,	0
GPGRVF	GPGRVF	NNP	B-NP
,	,	,	0
and	and	CC	0
GPGKVF	GPGKVF	NNP	B-NP
.	.	.	0
Kwong	Kwong	NNP	0
et	et	NNP	0
al.	al.	NNP	0
roughly	roughly	RB	0
divide	divide	VBP	0
the	the	DT	0
gp120	gp120	JJ	B-NP
three-dimensional	three-dimensional	JJ	I-NP
structure	structure	NN	I-NP
into	into	IN	0
outer	outer	JJ	0
(	(	-LRB-	0
β9-β19	β9-β19	NNP	0
and	and	CC	0
β22-β24	β22-β24	CD	0
)	)	-RRB-	0
and	and	CC	0
inner	inner	JJ	0
(	(	-LRB-	0
N-α1	N-α1	NNP	B-NP
,	,	,	0
β4-β8	β4-β8	NNP	0
,	,	,	0
and	and	CC	0
α5-C	α5-C	CD	B-NP
)	)	-RRB-	0
domains	domains	VBZ	0
joined	joined	VBN	0
by	by	IN	0
a	a	DT	0
bridging	bridging	JJ	0
sheet	sheet	NN	0
(	(	-LRB-	0
β2	β2	NNP	0
,	,	,	0
β3	β3	NNP	0
,	,	,	0
β20	β20	NNP	0
,	,	,	0
and	and	CC	0
β21	β21	CD	0
)	)	-RRB-	0
[	[	-LRB-	0
44	44	CD	0
]	]	-RRB-	0
.	.	.	0
As	As	RB	0
indicated	indicated	VBN	0
by	by	IN	0
Kwong	Kwong	NNP	0
et	et	NNP	0
al.	al.	NNP	0
,	,	,	0
all	all	DT	0
three	three	CD	0
domains	domains	NNS	0
include	include	VBP	0
variable	variable	JJ	0
regions	regions	NNS	0
;	;	:	0
as	as	IN	0
QUASI	QUASI	NNP	B-NP
shows	shows	VBZ	0
,	,	,	0
diversity	diversity	NN	0
in	in	IN	0
all	all	DT	0
three	three	CD	0
regions	regions	NNS	0
is	is	VBZ	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
we	we	PRP	0
find	find	VBP	0
rendered	rendered	VBN	0
by	by	IN	0
diversity	diversity	NN	0
in	in	IN	0
some	some	DT	0
of	of	IN	0
these	these	DT	0
regions	regions	NNS	0
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
the	the	DT	0
"silent	"silent	JJ	0
face	face	NN	0
"	"	''	0
)	)	-RRB-	0
has	has	VBZ	0
been	been	VBN	0
attributed	attributed	VBN	0
to	to	TO	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
[	[	-LRB-	0
44	44	CD	0
,	,	,	0
45	45	CD	0
]	]	-RRB-	0
,	,	,	0
thus	thus	RB	0
QUASI	QUASI	NNP	0
's	's	POS	0
results	results	NNS	0
run	run	VBP	0
counter	counter	RB	0
to	to	TO	0
previous	previous	JJ	0
interpretation	interpretation	NN	B-NP
.	.	.	0
That	That	WDT	0
is	is	VBZ	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
finds	finds	VBZ	0
that	that	DT	0
diversity	diversity	NN	0
in	in	IN	0
regions	regions	NNS	0
proposed	proposed	VBN	0
to	to	TO	0
be	be	VB	0
inaccessible	inaccessible	VBN	0
to	to	TO	0
the	the	DT	0
immune	immune	JJ	0
system	system	NN	0
nevertheless	nevertheless	RB	0
confers	confers	VBZ	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
on	on	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
.	.	.	0
QUASI	QUASI	NNP	0
's	's	POS	0
findings	findings	NNS	0
may	may	MD	0
be	be	VB	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
existence	existence	NN	0
of	of	IN	0
gaps	gaps	NN	0
in	in	IN	0
the	the	DT	0
carbohydrate	carbohydrate	JJ	B-NP
group	group	NN	I-NP
thought	thought	VBD	0
to	to	TO	0
mask	mask	VB	0
the	the	DT	0
silent	silent	JJ	0
face	face	NN	0
from	from	IN	0
gp120	gp120	CD	B-NP
from	from	IN	0
immune	immune	JJ	0
surveillance	surveillance	NN	B-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
in	in	IN	0
gp120	gp120	NNP	B-NP
carbohydrate-building	carbohydrate-building	JJ	I-NP
model	model	NN	I-NP
,	,	,	0
these	these	DT	0
gaps	gaps	JJ	0
correspond	correspond	NN	0
to	to	TO	0
codons	codons	VB	0
where	where	WRB	0
we	we	PRP	0
find	find	VBP	0
variation	variation	NN	0
is	is	VBZ	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
P	P	NN	0
.	.	.	0
Kwong	Kwong	NNP	0
,	,	,	0
per	per	IN	B-NP
commun.	commun.	CD	B-NP
)	)	-RRB-	0
.	.	.	0
A	A	DT	0
"non-neutralizing	"non-neutralizing	NN	0
"	"	''	0
face	face	NN	0
has	has	VBZ	0
been	been	VBN	0
identified	identified	VBN	0
where	where	WRB	0
binding	binding	JJ	0
antibody	antibody	NN	B-NP
generally	generally	RB	0
do	do	VBP	0
not	not	RB	0
neutralize	neutralize	JJ	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
when	when	WRB	0
gp120	gp120	NNP	B-NP
is	is	VBZ	0
oligomerized	oligomerized	JJ	0
[	[	-LRB-	0
45	45	CD	0
,	,	,	0
47	47	CD	0
]	]	-RRB-	0
;	;	:	0
these	these	DT	0
data	data	NNS	0
were	were	VBD	0
interpreted	interpreted	VBN	0
as	as	IN	0
indicating	indicating	VBG	0
that	that	IN	0
the	the	DT	0
non-neutralizing	non-neutralizing	JJ	B-NP
face	face	NN	I-NP
is	is	VBZ	0
occluded	occluded	VBN	0
in	in	IN	0
the	the	DT	0
trimer	trimer	NN	B-NP
and	and	CC	0
that	that	DT	0
binding	binding	JJ	0
antibody	antibody	NN	B-NP
are	are	VBP	0
raised	raised	VBN	0
against	against	IN	0
shed	shed	CD	B-NP
gp120	gp120	CD	I-NP
monomer	monomer	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
finds	finds	VBZ	0
numerous	numerous	JJ	0
positively	positively	NN	0
selected	selected	VBD	B-NP
variant	variant	JJ	I-NP
on	on	IN	0
the	the	DT	0
non-neutralizing	non-neutralizing	JJ	B-NP
face	face	NN	I-NP
of	of	IN	0
the	the	DT	0
inner	inner	JJ	0
domain	domain	NN	0
.	.	.	0
Assuming	Assuming	VBG	0
the	the	DT	0
"non-neutralizing	"non-neutralizing	NN	0
"	"	''	0
appellation	appellation	NN	B-NP
is	is	VBZ	0
appropriate	appropriate	JJ	0
,	,	,	0
how	how	WRB	0
do	do	VBP	0
mutations	mutations	VBN	0
on	on	IN	0
this	this	DT	0
face	face	NN	0
provide	provide	VBP	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
to	to	TO	0
the	the	DT	0
virus	virus	NN	0
?	?	.	0
The	The	DT	0
obvious	obvious	JJ	0
answer	answer	NN	0
is	is	VBZ	0
that	that	IN	0
mutations	mutations	NNS	0
provide	provide	VBP	0
escape	escape	VBN	0
not	not	RB	0
from	from	IN	0
direct	direct	JJ	0
B-cell	B-cell	JJ	B-NP
immunity	immunity	NN	I-NP
but	but	CC	0
from	from	IN	0
other	other	JJ	0
levels	levels	NNS	0
of	of	IN	0
immunity	immunity	NN	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
[	[	-LRB-	0
including	including	VBG	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	JJ	I-NP
complex	complex	NN	I-NP
(	(	-LRB-	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
complex	complex	JJ	I-NP
)	)	-RRB-	0
presentation	presentation	NN	B-NP
]	]	-RRB-	0
or	or	CC	0
indirect	indirect	JJ	0
Ab	Ab	JJ	B-NP
immunity	immunity	NN	I-NP
via	via	IN	0
Ab-dependent	Ab-dependent	JJ	B-NP
cellular	cellular	JJ	I-NP
cytotoxicity	cytotoxicity	NN	I-NP
(	(	-LRB-	0
where	where	WRB	0
gp120	gp120	JJ	B-NP
molecule	molecule	NN	I-NP
found	found	VBD	0
on	on	IN	0
infected	infected	JJ	0
cell	cell	NN	0
surfaces	surfaces	NNS	0
are	are	VBP	0
monomers	monomers	VBN	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
if	if	IN	0
viral	viral	VBD	B-NP
sequence	sequence	NN	I-NP
human	human	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
retain	retain	VB	0
evidence	evidence	NN	0
that	that	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
is	is	VBZ	0
a	a	DT	0
significant	significant	JJ	0
affecting	affecting	VBG	B-NP
hiv	hiv	NN	I-NP
quasispeciation	quasispeciation	NN	I-NP
selective	selective	JJ	I-NP
force	force	NN	I-NP
,	,	,	0
we	we	PRP	0
used	used	VBD	0
QUASI	QUASI	NNP	B-NP
to	to	TO	0
generate	generate	VB	0
a	a	DT	0
hiv-1	hiv-1	NN	B-NP
rt	rt	NN	I-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Because	Because	IN	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
is	is	VBZ	0
not	not	RB	0
a	a	DT	0
surface-expressed	surface-expressed	JJ	0
protein	protein	NN	B-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
not	not	RB	0
plausible	plausible	JJ	0
that	that	IN	0
the	the	DT	0
positively	positively	RB	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
selected	selected	VBN	I-NP
variant	variant	JJ	I-NP
have	have	VBP	0
been	been	VBN	0
selected	selected	VBN	0
by	by	IN	0
direct	direct	JJ	0
B-cell	B-cell	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
A	A	DT	0
priori	priori	NN	B-NP
,	,	,	0
RT	RT	NNP	B-NP
quasispeciation	quasispeciation	NN	I-NP
could	could	MD	0
have	have	VB	0
been	been	VBN	0
the	the	DT	0
result	result	NN	0
of	of	IN	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
,	,	,	0
but	but	CC	0
because	because	IN	0
QUASI	QUASI	NNP	B-NP
finds	finds	VBZ	0
that	that	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
confer	confer	VBP	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
on	on	IN	0
the	the	DT	0
virus	virus	NN	0
,	,	,	0
we	we	PRP	0
reject	reject	VBP	0
the	the	DT	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
hypothesis	hypothesis	NN	I-NP
at	at	IN	0
the	the	DT	0
22	22	CD	0
rt	rt	NN	B-NP
codon	codon	NN	I-NP
.	.	.	0
If	If	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
(	(	-LRB-	0
including	including	VBG	B-NP
MHC	MHC	NNP	I-NP
presentation	presentation	NN	I-NP
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
shaping	shaping	VBG	B-NP
rt	rt	NN	I-NP
quasispeciation	quasispeciation	NN	I-NP
selective	selective	JJ	I-NP
pressure	pressure	NN	I-NP
,	,	,	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
should	should	MD	0
be	be	VB	0
associated	associated	VBN	0
with	with	IN	0
t-cell	t-cell	NN	B-NP
epitope	epitope	NN	I-NP
.	.	.	0
When	When	WRB	0
known	known	VBN	0
t-cell	t-cell	NN	B-NP
epitope	epitope	NN	I-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
are	are	VBP	0
plotted	plotted	VBN	0
on	on	IN	0
the	the	DT	0
RT	RT	NNP	B-NP
selection	selection	NN	I-NP
map	map	NN	I-NP
,	,	,	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
found	found	VBN	0
to	to	TO	0
localize	localize	VB	0
significantly	significantly	RB	0
(	(	-LRB-	0
Fisher	Fisher	NNP	0
's	's	POS	0
exact	exact	JJ	0
test	test	NN	0
)	)	-RRB-	0
both	both	CC	0
with	with	IN	0
helper	helper	JJ	B-NP
t-cell	t-cell	NN	I-NP
epitope	epitope	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
3.27	3.27	CD	0
×	×	CD	0
10	10	CD	0
-2	-2	CD	0
)	)	-RRB-	0
and	and	CC	0
ctl	ctl	NN	B-NP
epitope	epitope	NN	I-NP
(	(	-LRB-	0
p	p	CD	0
=	=	SYM	0
6.58	6.58	CD	0
×	×	CD	0
10	10	CD	0
-3	-3	CD	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
conclude	conclude	VBP	0
that	that	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
is	is	VBZ	0
a	a	DT	0
significant	significant	JJ	0
selection	selection	NN	B-NP
pressure	pressure	NN	I-NP
shaping	shaping	VBG	0
the	the	DT	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
quasispeciation	quasispeciation	NN	I-NP
and	and	CC	0
presumably	presumably	RB	0
is	is	VBZ	0
a	a	DT	0
significant	significant	JJ	0
factor	factor	NN	B-NP
in	in	IN	0
the	the	DT	0
quasispeciation	quasispeciation	NN	B-NP
of	of	IN	0
other	other	JJ	0
hiv	hiv	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
because	because	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
gp120	gp120	CD	I-NP
variant	variant	JJ	I-NP
found	found	VBD	0
throughout	throughout	IN	0
gp120	gp120	NNP	B-NP
may	may	MD	0
be	be	VB	0
selected	selected	VBN	0
by	by	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
,	,	,	0
QUASI	QUASI	NNP	0
's	's	POS	0
finding	finding	NN	0
that	that	IN	0
the	the	DT	0
non-neutralizing	non-neutralizing	JJ	B-NP
face	face	NN	I-NP
includes	includes	VBZ	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
is	is	VBZ	0
not	not	RB	0
at	at	IN	0
odds	odds	NNS	0
with	with	IN	0
models	models	NNS	0
where	where	WRB	0
the	the	DT	0
non-neutralizing	non-neutralizing	JJ	B-NP
face	face	NN	I-NP
forms	forms	VBZ	0
the	the	DT	0
gp120	gp120	NN	B-NP
trimer	trimer	NN	I-NP
interface	interface	NN	I-NP
.	.	.	0
Nor	Nor	CC	0
are	are	VBP	0
QUASI	QUASI	NNP	0
's	's	POS	0
results	results	NNS	0
incompatible	incompatible	VBN	0
with	with	IN	0
the	the	DT	0
silent	silent	JJ	0
face	face	NN	0
being	being	VBG	0
silent	silent	JJ	0
to	to	TO	0
B-cell	B-cell	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
QUASI	QUASI	NNP	0
's	's	POS	0
finding	finding	NN	0
that	that	WDT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
may	may	MD	0
be	be	VB	0
buried	buried	VBN	0
in	in	IN	0
the	the	DT	0
gp120	gp120	JJ	B-NP
monomer	monomer	NN	I-NP
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
escape	escape	NN	0
from	from	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
the	the	DT	0
selection	selection	NN	B-NP
pressure	pressure	NN	I-NP
exerted	exerted	NN	I-NP
by	by	IN	0
T-cell	T-cell	JJ	B-NP
immunity	immunity	NN	I-NP
,	,	,	0
3	3	CD	0
'	'	POS	B-NP
-azido-3	-azido-3	NNP	I-NP
'	'	POS	I-NP
-deoxythymidine	-deoxythymidine	JJ	I-NP
(	(	-LRB-	0
AZT	AZT	NNP	B-NP
)	)	-RRB-	0
may	may	MD	0
also	also	RB	0
have	have	VBP	0
rt	rt	NN	B-NP
quasispeciation	quasispeciation	NN	I-NP
provided	provided	VBN	I-NP
selection	selection	NN	I-NP
pressure	pressure	NN	I-NP
in	in	IN	0
the	the	DT	0
sequences	sequences	JJ	0
selection	selection	NN	B-NP
mapped	mapped	NN	I-NP
by	by	IN	0
QUASI	QUASI	NNP	B-NP
[	[	-LRB-	0
59	59	CD	0
,	,	,	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
Indeed	Indeed	RB	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
identifies	identifies	VBZ	0
six	six	CD	0
of	of	IN	0
the	the	DT	0
eight	eight	CD	0
mutations	mutations	NNS	0
known	known	VBN	0
to	to	TO	0
be	be	VB	0
associated	associated	VBN	0
with	with	IN	0
AZT	AZT	NNP	B-NP
resistance	resistance	NN	I-NP
[	[	-LRB-	0
52	52	CD	0
]	]	-RRB-	0
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
N67	N67	NNP	B-NP
,	,	,	0
R70	R70	NNP	B-NP
,	,	,	0
W210	W210	NNP	B-NP
,	,	,	0
Y215	Y215	NNP	B-NP
,	,	,	0
and	and	CC	0
F215	F215	CD	B-NP
)	)	-RRB-	0
or	or	CC	0
possibly	possibly	RB	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
L41	L41	NNP	B-NP
)	)	-RRB-	0
to	to	TO	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
exceptions	exceptions	NNS	0
,	,	,	0
two	two	CD	0
mutations	mutations	NNS	0
of	of	IN	0
codon	codon	CD	B-NP
219	219	CD	0
,	,	,	0
are	are	VBP	0
informative	informative	VBN	0
.	.	.	0
Whereas	Whereas	IN	0
mutations	mutations	NNS	0
at	at	IN	0
other	other	JJ	0
codon	codon	NN	B-NP
are	are	VBP	0
necessary	necessary	JJ	0
for	for	IN	0
high	high	JJ	0
resistance	resistance	NN	0
to	to	TO	0
AZT	AZT	NNP	B-NP
,	,	,	0
mutations	mutations	NNS	0
at	at	IN	0
codon	codon	CD	B-NP
219	219	CD	0
are	are	VBP	0
not	not	RB	0
,	,	,	0
and	and	CC	0
codon	codon	CD	B-NP
219	219	CD	0
mutations	mutations	NNS	0
arise	arise	VBP	0
late	late	RB	0
in	in	IN	0
infection	infection	NN	B-NP
after	after	IN	0
earlier	earlier	JJR	0
mutations	mutations	NNS	0
have	have	VBP	0
already	already	RB	0
rendered	rendered	VBN	B-NP
RT	RT	NNP	I-NP
resistant	resistant	VBD	0
to	to	TO	0
AZT	AZT	NNP	B-NP
[	[	-LRB-	0
53	53	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
conclude	conclude	VBP	0
that	that	IN	0
the	the	DT	0
additional	additional	JJ	0
AZT	AZT	NNP	B-NP
resistance	resistance	NN	I-NP
conferred	conferred	NN	I-NP
by	by	IN	0
codon	codon	CD	B-NP
219	219	CD	0
mutations	mutations	NNS	0
did	did	VBD	0
not	not	RB	0
provide	provide	VB	0
significant	significant	JJ	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
to	to	TO	0
the	the	DT	0
profiled	profiled	JJ	0
hiv	hiv	NN	B-NP
virus	virus	NN	I-NP
,	,	,	0
possibly	possibly	RB	0
because	because	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
had	had	VBD	0
already	already	RB	0
acquired	acquired	VBN	0
the	the	DT	0
maximum	maximum	JJ	0
effective	effective	JJ	0
AZT	AZT	NNP	B-NP
resistance	resistance	NN	I-NP
selectable	selectable	NN	I-NP
,	,	,	0
in	in	IN	0
vivo	vivo	NN	B-NP
,	,	,	0
when	when	WRB	0
mutations	mutations	NNS	0
arose	arose	VBD	0
at	at	IN	0
this	this	DT	0
codon	codon	NN	B-NP
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
the	the	DT	0
lysine	lysine	NN	B-NP
at	at	IN	0
codon	codon	CD	B-NP
219	219	CD	0
may	may	MD	0
be	be	VB	0
important	important	JJ	0
for	for	IN	0
proper	proper	JJ	0
in	in	IN	0
vivo	vivo	JJ	B-NP
RT	RT	NN	I-NP
function	function	VBP	0
such	such	JJ	0
that	that	IN	0
the	the	DT	0
advantage	advantage	NN	B-NP
conferred	conferred	NN	I-NP
by	by	IN	0
increased	increased	JJ	0
AZT	AZT	NNP	B-NP
resistance	resistance	NN	I-NP
does	does	VBZ	0
not	not	RB	0
adequately	adequately	RB	0
compensate	compensate	VB	0
for	for	IN	0
impaired	impaired	JJ	0
RT	RT	NNP	B-NP
function	function	NN	I-NP
.	.	.	0
The	The	DT	0
rt	rt	NN	B-NP
sequence	sequence	NN	I-NP
we	we	PRP	0
analyze	analyze	VBP	0
were	were	VBD	0
taken	taken	VBN	0
from	from	IN	0
patients	patients	NNS	0
who	who	WP	0
either	either	RB	0
had	had	VBD	0
no	no	DT	0
anti-RT	anti-RT	JJ	B-NP
treatment	treatment	NN	I-NP
or	or	CC	0
were	were	VBD	0
treated	treated	VBN	0
mainly	mainly	RB	0
with	with	IN	0
AZT	AZT	NNP	B-NP
(	(	-LRB-	0
though	though	IN	0
some	some	DT	0
patients	patients	NNS	0
who	who	WP	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
AZT	AZT	NNP	B-NP
were	were	VBD	0
also	also	RB	0
treated	treated	VBN	0
with	with	IN	0
2	2	CD	0
'	'	POS	0
,	,	,	0
3	3	CD	0
'	'	POS	B-NP
-dideoxyinosine	-dideoxyinosine	JJ	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
49	49	CD	0
,	,	,	0
50	50	CD	0
,	,	,	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
would	would	MD	0
predict	predict	VB	0
that	that	IN	0
mutations	mutations	NNS	0
associated	associated	VBN	0
with	with	IN	0
resistance	resistance	NN	0
to	to	TO	0
other	other	JJ	0
anti-rt	anti-rt	NN	B-NP
drug	drug	NN	I-NP
should	should	MD	0
not	not	RB	0
be	be	VB	0
positively	positively	RB	0
selected	selected	VBN	0
in	in	IN	0
the	the	DT	0
sequences	sequences	JJ	0
QUASI	QUASI	NNP	B-NP
analyzed	analyzed	VBD	0
.	.	.	0
As	As	RB	0
predicted	predicted	VBD	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
identifies	identifies	VBZ	0
none	none	NN	0
of	of	IN	0
the	the	DT	0
50	50	CD	0
RT	RT	NN	B-NP
mutation	mutation	VBP	I-NP
associated	associated	VBN	0
with	with	IN	0
resistance	resistance	NN	0
to	to	TO	0
other	other	JJ	0
drugs	drugs	NNS	0
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
compare	compare	VB	0
Figure	Figure	NN	0
4to	4to	VBZ	0
the	the	DT	0
Los	Los	NNP	0
Alamos	Alamos	NNP	0
database	database	NN	0
[	[	-LRB-	0
52	52	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
Conclusion	Conclusion	NN	0
We	We	PRP	0
have	have	VBP	0
developed	developed	VBN	0
an	an	DT	0
algorithm	algorithm	NN	B-NP
for	for	IN	0
using	using	VBG	0
sequence	sequence	JJ	0
data	data	NNS	0
to	to	TO	0
map	map	VB	0
the	the	DT	0
positively	positively	RB	0
viral	viral	JJ	B-NP
quasispecy	quasispecy	NN	I-NP
selected	selected	VBN	I-NP
mutation	mutation	NN	I-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
used	used	VBN	0
this	this	DT	0
method	method	NN	0
to	to	TO	0
map	map	VB	0
the	the	DT	0
positively	positively	RB	0
influenza	influenza	VBG	B-NP
selected	selected	VBN	I-NP
variant	variant	JJ	I-NP
A	A	DT	0
hemagglutinin	hemagglutinin	NN	B-NP
,	,	,	0
HIV-1	HIV-1	NNP	B-NP
RT	RT	NNP	I-NP
,	,	,	0
and	and	CC	0
HIV-1	HIV-1	NNP	B-NP
gp120	gp120	NNP	I-NP
.	.	.	0
Other	Other	JJ	0
obvious	obvious	JJ	0
targets	targets	NNS	0
for	for	IN	0
selection	selection	NN	0
mapping	mapping	NNS	0
are	are	VBP	0
the	the	DT	0
hepatitis	hepatitis	NNP	0
C	C	NNP	0
and	and	CC	0
foot-and-mouth	foot-and-mouth	JJ	0
disease	disease	NN	B-NP
virus	virus	NN	I-NP
.	.	.	0
We	We	PRP	0
believe	believe	VBP	0
that	that	IN	0
potentially	potentially	RB	0
the	the	DT	0
most	most	RBS	0
illuminating	illuminating	JJ	0
use	use	NN	0
of	of	IN	0
selection	selection	NN	B-NP
mapping	mapping	NN	I-NP
may	may	MD	0
be	be	VB	0
the	the	DT	0
comparison	comparison	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
subpopulation	subpopulation	NN	I-NP
to	to	TO	0
determine	determine	VB	0
which	which	WDT	0
variants	variants	NNS	0
are	are	VBP	0
advantageous	advantageous	VBN	0
under	under	IN	0
different	different	JJ	0
selective	selective	JJ	B-NP
pressure	pressure	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
selection	selection	NN	I-NP
mapping	mapping	NN	I-NP
isolates	isolates	VBZ	0
with	with	IN	0
different	different	JJ	0
cellular	cellular	JJ	B-NP
tropism	tropism	NN	I-NP
will	will	MD	0
allow	allow	VB	0
the	the	DT	0
determination	determination	NN	B-NP
of	of	IN	0
mutations	mutations	NNS	0
that	that	WDT	0
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
host	host	NN	B-NP
cell	cell	NN	I-NP
type	type	NN	I-NP
.	.	.	0
Also	Also	RB	0
,	,	,	0
we	we	PRP	0
may	may	MD	0
use	use	VB	0
selection	selection	NN	B-NP
mapping	mapping	NN	I-NP
to	to	TO	0
analyze	analyze	VB	0
hiv	hiv	NN	B-NP
breakthrough	breakthrough	NN	I-NP
infection	infection	NN	I-NP
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
vaccines	vaccines	NNS	0
prevented	prevented	VBD	0
the	the	DT	0
hiv	hiv	NN	B-NP
quasispecy	quasispecy	NN	I-NP
from	from	IN	0
inhabiting	inhabiting	VBG	0
normally	normally	RB	0
advantageous	advantageous	JJ	0
regions	regions	NNS	0
of	of	IN	0
the	the	DT	0
quasispecies	quasispecies	JJ	B-NP
sequence	sequence	NN	I-NP
space	space	NN	I-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
we	we	PRP	0
propose	propose	VBP	0
that	that	IN	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	0
viral	viral	JJ	B-NP
variant	variant	JJ	I-NP
(	(	-LRB-	0
as	as	RB	0
opposed	opposed	VBN	0
to	to	TO	0
all	all	DT	0
viral	viral	JJ	B-NP
variant	variant	JJ	I-NP
)	)	-RRB-	0
should	should	MD	0
be	be	VB	0
included	included	VBN	0
in	in	IN	0
future	future	NN	0
,	,	,	0
highly	highly	RB	0
multivalent	multivalent	JJ	B-NP
vaccine	vaccine	NN	I-NP
designed	designed	VBN	0
to	to	TO	0
compensate	compensate	VB	0
for	for	IN	0
B-cell-selected	B-cell-selected	JJ	B-NP
antigenic	antigenic	JJ	I-NP
drift	drift	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
QUASI--the	QUASI--the	JJ	B-NP
selection	selection	NN	I-NP
mapping	mapping	NN	I-NP
algorithm	algorithm	VBD	0
An	An	DT	0
quasi	quasi	NN	B-NP
software	software	NN	I-NP
executable	executable	JJ	I-NP
version	version	NN	I-NP
is	is	VBZ	0
attached	attached	VBN	0
as	as	IN	0
an	an	DT	0
additional	additional	JJ	0
file	file	NN	0
(	(	-LRB-	0
see	see	VB	0
additional	additional	JJ	0
file	file	NN	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Also	Also	RB	0
attached	attached	VBN	0
are	are	VBP	0
a	a	DT	0
users	users	NNS	0
'	'	POS	0
manual	manual	NN	0
(	(	-LRB-	0
user.txt	user.txt	NNP	0
-	-	:	0
see	see	VB	0
additional	additional	JJ	0
file	file	NN	0
2	2	CD	0
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
FASTA	FASTA	NNP	B-NP
to	to	TO	0
QUASI	QUASI	NNP	B-NP
file	file	NN	I-NP
converter	converter	NN	I-NP
PERL	PERL	NNP	I-NP
script	script	NN	I-NP
(	(	-LRB-	0
F2Q.pl	F2Q.pl	NNP	0
-	-	:	0
additional	additional	JJ	0
file	file	NN	0
3	3	LS	0
)	)	-RRB-	0
.	.	.	0
quasi	quasi	NN	B-NP
current	current	JJ	I-NP
version	version	NN	I-NP
are	are	VBP	0
available	available	JJ	0
from	from	IN	0
the	the	DT	0
authors	authors	NNS	0
or	or	CC	0
may	may	MD	0
be	be	VB	0
accessed	accessed	VBN	0
at	at	IN	0
the	the	DT	0
Los	Los	NNP	0
Alamos	Alamos	NNP	0
Influenza	Influenza	NNP	0
Sequence	Sequence	NNP	0
Database	Database	NNP	0
(	(	-LRB-	0
http://www.flu.lanl.gov/	http://www.flu.lanl.gov/	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
a	a	DT	0
set	set	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
nucleotide	nucleotide	JJ	I-NP
sequence	sequence	NN	I-NP
,	,	,	0
we	we	PRP	0
determine	determine	VBP	0
the	the	DT	0
variants	variants	NN	0
that	that	WDT	0
confer	confer	VBP	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
by	by	IN	0
measuring	measuring	VBG	0
the	the	DT	0
empirical	empirical	JJ	B-NP
replacement	replacement	NN	I-NP
to	to	TO	0
silent	silent	JJ	0
mutation	mutation	NN	B-NP
ratio	ratio	NN	I-NP
(	(	-LRB-	0
R	R	NNP	0
:	:	:	0
S	S	NNP	0
)	)	-RRB-	0
of	of	IN	0
each	each	DT	0
possible	possible	JJ	0
amino	amino	JJ	0
acid	acid	NN	B-NP
replacement	replacement	NN	I-NP
and	and	CC	0
then	then	RB	0
comparing	comparing	VBG	0
this	this	DT	0
observed	observed	JJ	0
ratio	ratio	NN	0
to	to	TO	0
that	that	IN	0
which	which	WDT	0
would	would	MD	0
be	be	VB	0
expected	expected	VBN	0
if	if	IN	0
mutation	mutation	NN	0
were	were	VBD	0
unselected	unselected	VBN	0
.	.	.	0
An	An	DT	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
that	that	WDT	0
is	is	VBZ	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
higher	higher	JJR	0
than	than	IN	0
expected	expected	JJ	0
indicates	indicates	NN	0
that	that	IN	0
the	the	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
tested	tested	NN	I-NP
is	is	VBZ	0
positively	positively	RB	0
selected	selected	VBN	0
,	,	,	0
while	while	IN	0
a	a	DT	0
lower-than-expected	lower-than-expected	JJ	B-NP
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
indicates	indicates	VBZ	0
that	that	IN	0
the	the	DT	0
tested	tested	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
is	is	VBZ	0
negatively	negatively	RB	0
selected	selected	VBN	0
.	.	.	0
Testing	Testing	NN	0
for	for	IN	0
an	an	DT	0
replacement	replacement	NN	B-NP
overabundance	overabundance	NN	I-NP
across	across	IN	0
a	a	DT	0
protein	protein	NN	B-NP
as	as	IN	0
a	a	DT	0
whole	whole	NN	0
is	is	VBZ	0
a	a	DT	0
reasonable	reasonable	JJ	0
approach	approach	NN	0
when	when	WRB	0
only	only	RB	0
a	a	DT	0
few	few	JJ	0
nucleotide	nucleotide	JJ	B-NP
sequence	sequence	NN	I-NP
are	are	VBP	0
available	available	JJ	0
,	,	,	0
but	but	CC	0
because	because	IN	0
a	a	DT	0
large	large	JJ	0
number	number	NN	0
of	of	IN	0
mutated	mutated	JJ	B-NP
viral	viral	JJ	I-NP
sequence	sequence	NN	I-NP
are	are	VBP	0
currently	currently	RB	0
available	available	JJ	0
,	,	,	0
such	such	JJ	0
aggregation	aggregation	NN	B-NP
is	is	VBZ	0
unnecessarily	unnecessarily	RB	0
crude	crude	JJ	0
.	.	.	0
Better	Better	RB	0
are	are	VBP	0
approaches	approaches	NNS	0
that	that	IN	0
test	test	NN	0
for	for	IN	0
an	an	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
overabundance	overabundance	NN	I-NP
at	at	IN	0
individual	individual	JJ	B-NP
codon	codon	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
36	36	CD	0
,	,	,	0
37	37	CD	0
,	,	,	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
these	these	DT	0
methods	methods	NNS	0
lump	lump	VBP	0
together	together	RB	0
replacement	replacement	JJ	B-NP
mutation	mutation	NN	I-NP
and	and	CC	0
thus	thus	RB	0
allow	allow	VB	0
negatively	negatively	RB	0
selected	selected	VBN	B-NP
mutation	mutation	NN	I-NP
to	to	TO	0
conceal	conceal	VB	0
positively	positively	RB	0
selected	selected	VBN	B-NP
mutation	mutation	NN	I-NP
and	and	CC	0
vice	vice	NN	B-NP
versa	versa	NN	I-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
at	at	IN	0
a	a	DT	0
codon	codon	NN	B-NP
may	may	MD	0
be	be	VB	0
negatively	negatively	RB	0
selected	selected	VBN	0
as	as	IN	0
a	a	DT	0
group	group	NN	0
despite	despite	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
one	one	CD	0
or	or	CC	0
more	more	RBR	0
particular	particular	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
overcome	overcome	VB	0
these	these	DT	0
limitations	limitations	NNS	0
,	,	,	0
the	the	DT	0
QUASI	QUASI	NNP	B-NP
algorithm	algorithm	NN	I-NP
does	does	VBZ	0
not	not	RB	0
test	test	VB	0
the	the	DT	0
overall	overall	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
the	the	DT	0
entire	entire	JJ	0
protein	protein	NN	B-NP
as	as	IN	0
an	an	DT	0
aggregate	aggregate	NN	B-NP
,	,	,	0
nor	nor	CC	0
does	does	VBZ	0
QUASI	QUASI	NNP	B-NP
test	test	NN	I-NP
the	the	DT	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
a	a	DT	0
codon	codon	NN	B-NP
to	to	TO	0
all	all	PDT	0
its	its	PRP$	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
taken	taken	VBN	0
as	as	IN	0
a	a	DT	0
whole	whole	NN	0
.	.	.	0
Rather	Rather	RB	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
tests	tests	VBZ	0
the	the	DT	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
each	each	DT	0
particular	particular	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
at	at	IN	0
each	each	DT	0
codon	codon	NN	B-NP
.	.	.	0
That	That	WDT	0
is	is	VBZ	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
measures	measures	VBZ	0
the	the	DT	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
the	the	DT	0
mutations	mutations	NN	0
from	from	IN	0
a	a	DT	0
consensus	consensus	NN	B-NP
codon	codon	NN	I-NP
towards	towards	IN	0
each	each	DT	0
individual	individual	JJ	B-NP
replacement	replacement	NN	I-NP
amino	amino	NN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
if	if	IN	0
the	the	DT	0
consensus	consensus	NN	B-NP
codon	codon	NN	I-NP
at	at	IN	0
a	a	DT	0
protein	protein	NN	B-NP
position	position	NN	I-NP
were	were	VBD	0
ttt	ttt	NN	B-NP
(	(	-LRB-	0
Phe	Phe	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
QUASI	QUASI	NNP	B-NP
would	would	MD	0
test	test	VB	0
the	the	DT	0
R	R	NN	0
:	:	:	0
		NN	B-NP
of	of	IN	0
all	all	DT	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
from	from	IN	0
ttt	ttt	NN	B-NP
.	.	.	0
One	One	CD	0
of	of	IN	0
these	these	DT	0
mutations	mutations	NN	0
is	is	VBZ	0
ttt→tat	ttt→tat	NNP	B-NP
(	(	-LRB-	0
Tyr	Tyr	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
QUASI	QUASI	NNP	B-NP
calculates	calculates	VBZ	0
the	the	DT	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
for	for	IN	0
ttt→tat	ttt→tat	CD	B-NP
under	under	IN	0
the	the	DT	0
null	null	JJ	0
hypothesis	hypothesis	NN	0
of	of	IN	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
.	.	.	0
The	The	DT	0
expected	expected	VBN	B-NP
S	S	NNP	I-NP
is	is	VBZ	0
one	one	CD	0
because	because	IN	0
only	only	RB	0
one	one	CD	0
mutation	mutation	NNS	0
(	(	-LRB-	0
ttc	ttc	LS	B-NP
)	)	-RRB-	0
is	is	VBZ	0
silent	silent	JJ	0
,	,	,	0
and	and	CC	0
the	the	DT	0
expected	expected	JJ	0
R	R	NN	0
is	is	VBZ	0
also	also	RB	0
one	one	CD	0
because	because	IN	0
only	only	RB	0
one	one	CD	0
ttt	ttt	NNS	B-NP
point	point	NN	I-NP
mutation	mutation	NN	I-NP
(	(	-LRB-	0
tat	tat	LS	0
)	)	-RRB-	0
codes	codes	NNS	0
for	for	IN	0
Tyr	Tyr	NNP	B-NP
,	,	,	0
so	so	RB	0
the	the	DT	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
one	one	CD	0
,	,	,	0
in	in	IN	0
this	this	DT	0
case	case	NN	0
.	.	.	0
If	If	IN	0
QUASI	QUASI	NNP	B-NP
rejects	rejects	VBZ	0
the	the	DT	0
(	(	-LRB-	0
Jukes-Cantor	Jukes-Cantor	NNP	B-NP
)	)	-RRB-	0
neutral	neutral	FW	0
drift	drift	FW	0
null	null	FW	0
hypothesis	hypothesis	FW	0
because	because	IN	0
the	the	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
significantly	significantly	RB	0
higher	higher	JJR	0
than	than	IN	0
one	one	CD	0
,	,	,	0
then	then	RB	0
QUASI	QUASI	NNP	B-NP
classifies	classifies	VBZ	0
this	this	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
(	(	-LRB-	0
Tyr	Tyr	NNP	B-NP
)	)	-RRB-	0
as	as	IN	0
positively	positively	RB	0
selected	selected	VBN	0
.	.	.	0
Conversely	Conversely	RB	0
,	,	,	0
if	if	IN	0
QUASI	QUASI	NNP	B-NP
rejects	rejects	VBZ	0
the	the	DT	0
null	null	JJ	0
hypothesis	hypothesis	NN	0
because	because	IN	0
the	the	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
significantly	significantly	RB	0
lower	lower	JJR	0
than	than	IN	0
one	one	CD	0
,	,	,	0
then	then	RB	0
QUASI	QUASI	JJ	0
determines	determines	NN	0
that	that	IN	0
this	this	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
is	is	VBZ	0
negatively	negatively	RB	0
selected	selected	VBN	0
.	.	.	0
QUASI	QUASI	NNP	B-NP
performs	performs	VBZ	0
this	this	DT	0
procedure	procedure	NN	0
for	for	IN	0
all	all	DT	0
replacement	replacement	NN	B-NP
point	point	NN	I-NP
mutation	mutation	NN	I-NP
[	[	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
in	in	IN	0
the	the	DT	0
example	example	NN	B-NP
case	case	NN	I-NP
,	,	,	0
Tyr	Tyr	NNP	B-NP
(	(	-LRB-	0
tat	tat	LS	0
)	)	-RRB-	0
,	,	,	0
Ile	Ile	NNP	B-NP
(	(	-LRB-	0
att	att	LS	B-NP
)	)	-RRB-	0
,	,	,	0
Leu	Leu	NNP	0
(	(	-LRB-	0
tta	tta	UH	B-NP
,	,	,	0
ttg	ttg	NN	B-NP
,	,	,	0
and	and	CC	0
ctt	ctt	CD	B-NP
)	)	-RRB-	0
,	,	,	0
Val	Val	NNP	0
(	(	-LRB-	0
gtt	gtt	LS	B-NP
)	)	-RRB-	0
,	,	,	0
Ser	Ser	NNP	0
(	(	-LRB-	0
tct	tct	LS	B-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
cy	cy	NN	B-NP
(	(	-LRB-	0
tgt	tgt	LS	B-NP
)	)	-RRB-	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
this	this	DT	0
paper	paper	NN	0
,	,	,	0
selection	selection	NN	B-NP
mapping	mapping	NN	I-NP
is	is	VBZ	0
carried	carried	VBN	0
out	out	RP	0
independent	independent	JJ	0
of	of	IN	0
the	the	DT	0
underlying	underlying	JJ	0
phylogeny	phylogeny	NN	B-NP
.	.	.	0
QUASI	QUASI	NNP	B-NP
uses	uses	VBZ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
to	to	TO	0
reject	reject	VB	0
the	the	DT	0
null	null	JJ	0
hypothesis	hypothesis	NN	0
that	that	IN	0
the	the	DT	0
mutational	mutational	JJ	B-NP
space	space	NN	I-NP
surrounding	surrounding	VBG	0
the	the	DT	0
consensus	consensus	NN	B-NP
codon	codon	NN	I-NP
is	is	VBZ	0
distributed	distributed	VBN	0
randomly	randomly	RB	0
among	among	IN	0
all	all	DT	0
nine	nine	CD	0
possible	possible	JJ	0
R	R	NN	0
or	or	CC	0
		NN	B-NP
point	point	NN	I-NP
mutation	mutation	NN	I-NP
(	(	-LRB-	0
except	except	IN	0
stop	stop	NN	B-NP
codon	codon	NN	I-NP
,	,	,	0
which	which	WDT	0
are	are	VBP	0
considered	considered	VBN	0
to	to	TO	0
be	be	VB	0
disallowed	disallowed	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
allows	allows	JJ	0
R	R	NN	0
:	:	:	0
		NN	B-NP
calculation	calculation	NN	I-NP
to	to	TO	0
be	be	VB	0
applied	applied	VBN	0
to	to	TO	0
viral	viral	JJ	B-NP
sequence	sequence	NN	I-NP
whose	whose	WP$	0
ancestral	ancestral	JJ	B-NP
sequence	sequence	NN	I-NP
is	is	VBZ	0
unclear	unclear	JJ	0
or	or	CC	0
unknown	unknown	NN	B-NP
.	.	.	0
This	This	DT	0
is	is	VBZ	0
a	a	DT	0
both	both	PDT	0
an	an	DT	0
advantage	advantage	NN	0
and	and	CC	0
a	a	DT	0
disadvantage	disadvantage	NN	B-NP
over	over	IN	0
analyses	analyses	NNS	0
that	that	WDT	0
rely	rely	VBP	0
on	on	IN	0
phylogeny	phylogeny	NN	B-NP
.	.	.	0
Phylogeny	Phylogeny	NNP	B-NP
is	is	VBZ	0
difficult	difficult	JJ	0
to	to	TO	0
determine	determine	VB	0
accurately	accurately	RB	0
and	and	CC	0
uniquely	uniquely	RB	0
,	,	,	0
and	and	CC	0
relying	relying	VBG	0
on	on	IN	0
phylogeny	phylogeny	NN	B-NP
ignores	ignores	VBZ	0
the	the	DT	0
persistence	persistence	NN	0
of	of	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
replacement	replacement	NN	I-NP
mutation	mutation	NN	I-NP
(	(	-LRB-	0
the	the	DT	0
major	major	JJ	0
effect	effect	NN	0
of	of	IN	0
selection	selection	NN	0
)	)	-RRB-	0
.	.	.	0
On	On	IN	0
a	a	DT	0
practical	practical	JJ	B-NP
level	level	NN	I-NP
,	,	,	0
using	using	VBG	0
phylogeny	phylogeny	NN	B-NP
to	to	TO	0
reconstruct	reconstruct	VB	0
viruses	viruses	NN	0
'	'	POS	0
mutational	mutational	JJ	B-NP
history	history	NN	I-NP
and	and	CC	0
then	then	RB	0
using	using	VBG	0
intuited	intuited	JJ	0
mutations	mutations	NN	0
leaves	leaves	VBZ	0
one	one	CD	0
with	with	IN	0
insufficient	insufficient	JJ	0
data	data	NNS	0
to	to	TO	0
determine	determine	VB	0
positively-selected	positively-selected	JJ	0
codon	codon	NN	B-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
unless	unless	IN	0
,	,	,	0
as	as	IN	0
some	some	DT	0
have	have	VBP	0
done	done	VBN	0
,	,	,	0
one	one	PRP	0
assumes	assumes	VBZ	0
observed	observed	VBN	B-NP
drift	drift	NN	I-NP
is	is	VBZ	0
neutral	neutral	JJ	0
and	and	CC	0
then	then	RB	0
tests	tests	NNS	0
for	for	IN	0
codon	codon	NN	B-NP
where	where	WRB	0
selection	selection	NN	0
is	is	VBZ	0
more	more	RBR	0
positive	positive	JJ	0
than	than	IN	0
average	average	NN	0
[	[	-LRB-	0
23	23	CD	0
,	,	,	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
significance	significance	NN	B-NP
problem	problem	NN	I-NP
can	can	MD	0
be	be	VB	0
compounded	compounded	VBN	0
when	when	WRB	0
one	one	PRP	0
is	is	VBZ	0
looking	looking	VBG	0
for	for	IN	0
independent	independent	JJ	0
occurrences	occurrences	NNS	0
of	of	IN	0
particular	particular	JJ	0
mutations	mutations	NNS	0
;	;	:	0
often	often	RB	0
,	,	,	0
there	there	EX	0
simply	simply	RB	0
has	has	VBZ	0
not	not	RB	0
been	been	VBN	0
enough	enough	RB	0
sequence	sequence	JJ	B-NP
evolution	evolution	NN	I-NP
in	in	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
or	or	CC	0
influenza	influenza	JJ	B-NP
to	to	TO	0
map	map	VB	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
if	if	IN	0
the	the	DT	0
retention	retention	NN	0
of	of	IN	0
positively	positively	RB	0
selected	selected	VBN	B-NP
mutation	mutation	NN	I-NP
is	is	VBZ	0
ignored	ignored	VBN	0
.	.	.	0
The	The	DT	0
drawback	drawback	NN	0
of	of	IN	0
ignoring	ignoring	VBG	B-NP
phylogeny	phylogeny	NN	I-NP
is	is	VBZ	0
a	a	DT	0
potentially	potentially	RB	0
high	high	JJ	0
false	false	JJ	0
positive	positive	JJ	B-NP
rate	rate	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
below	below	IN	0
)	)	-RRB-	0
.	.	.	0
Empirical	Empirical	NNP	0
R	R	NNP	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
compared	compared	VBN	0
to	to	TO	0
neutral	neutral	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
by	by	IN	0
means	means	NNS	0
of	of	IN	0
a	a	DT	0
two-sided	two-sided	JJ	0
test	test	NN	0
of	of	IN	0
the	the	DT	0
binomial	binomial	JJ	0
distribution	distribution	NN	0
.	.	.	0
For	For	IN	0
each	each	DT	0
codon	codon	NN	0
,	,	,	0
we	we	PRP	0
test	test	VBP	0
the	the	DT	0
null	null	JJ	0
hypothesis	hypothesis	NN	0
that	that	IN	0
all	all	DT	0
nine	nine	CD	0
point	point	NN	0
mutants	mutants	NNS	0
are	are	VBP	0
equally	equally	RB	0
probable	probable	JJ	0
.	.	.	0
The	The	DT	0
quotient	quotient	JJ	0
p	p	NN	0
=	=	SYM	0
R	R	NNP	0
/	/	NNP	0
(	(	-LRB-	0
R+S	R+S	NNP	0
)	)	-RRB-	0
is	is	VBZ	0
the	the	DT	0
probability	probability	NN	0
of	of	IN	0
a	a	DT	0
replacement	replacement	NN	0
mutation	mutation	NN	0
at	at	IN	0
this	this	DT	0
codon	codon	NN	0
if	if	IN	0
each	each	DT	0
nucleotide	nucleotide	NN	0
is	is	VBZ	0
equally	equally	RB	0
mutable	mutable	JJ	0
and	and	CC	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
three	three	CD	0
mutational	mutational	CD	0
targets	targets	NNS	0
at	at	IN	0
that	that	DT	0
codon	codon	NNS	0
are	are	VBP	0
equally	equally	RB	0
likely	likely	JJ	0
.	.	.	0
The	The	DT	0
numerator	numerator	NN	0
,	,	,	0
R	R	NNP	0
,	,	,	0
is	is	VBZ	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
point	point	NN	0
mutations	mutations	NNS	0
that	that	IN	0
lead	lead	NN	0
from	from	IN	0
the	the	DT	0
consensus	consensus	NN	0
codon	codon	NN	0
to	to	TO	0
the	the	DT	0
target	target	NN	0
amino	amino	NN	0
acid	acid	NN	0
.	.	.	0
The	The	DT	0
chance	chance	NN	0
of	of	IN	0
observing	observing	VBG	0
r	r	JJ	0
replacement	replacement	NN	0
mutations	mutations	NN	0
is	is	VBZ	0
given	given	VBN	0
by	by	IN	0
the	the	DT	0
binomial	binomial	JJ	0
distribution	distribution	NN	0
,	,	,	0
,	,	,	0
where	where	WRB	0
n	n	NN	0
is	is	VBZ	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
codons	codons	NNS	0
providing	providing	VBG	0
data	data	NNS	0
for	for	IN	0
this	this	DT	0
position	position	NN	0
.	.	.	0
To	To	TO	0
form	form	VB	0
a	a	DT	0
two-sided	two-sided	JJ	0
test	test	NN	0
,	,	,	0
we	we	PRP	0
sum	sum	VB	0
all	all	DT	0
terms	terms	NNS	0
b	b	SYM	0
(	(	-LRB-	0
kn	kn	UH	0
,	,	,	0
,	,	CD	0
p	p	CD	0
)	)	-RRB-	0
such	such	JJ	0
that	that	IN	0
b	b	NNS	0
(	(	-LRB-	0
kn	kn	UH	0
,	,	,	0
,	,	CD	0
p	p	CD	0
)	)	-RRB-	0
is	is	VBZ	0
not	not	RB	0
greater	greater	JJR	0
than	than	IN	0
b	b	NNS	0
(	(	-LRB-	0
rn	rn	UH	0
,	,	,	0
p	p	NN	0
,	,	,	0
)	)	NNP	0
,	,	,	0
where	where	WRB	0
k	k	NN	0
is	is	VBZ	0
in	in	IN	0
the	the	DT	0
set	set	NN	0
(	(	-LRB-	0
0	0	CD	0
,	,	,	0
...	...	NNP	0
,	,	,	0
n	n	CD	0
)	)	-RRB-	0
and	and	CC	0
r	r	NN	0
is	is	VBZ	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
observed	observed	JJ	0
replacement	replacement	NN	0
mutations	mutations	NNS	0
.	.	.	0
In	In	IN	0
other	other	JJ	0
words	words	NNS	0
,	,	,	0
we	we	PRP	0
sum	sum	VB	0
the	the	DT	0
chances	chances	NNS	0
of	of	IN	0
all	all	DT	0
events	events	NNS	0
that	that	WDT	0
are	are	VBP	0
no	no	RB	0
more	more	RBR	0
likely	likely	JJ	0
than	than	IN	0
that	that	DT	0
of	of	IN	0
the	the	DT	0
observation	observation	NN	0
.	.	.	0
If	If	IN	0
this	this	DT	0
sum	sum	NN	0
,	,	,	0
α	α	NN	0
,	,	,	0
is	is	VBZ	0
small	small	JJ	0
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
not	not	RB	0
greater	greater	JJR	0
than	than	IN	0
0.05	0.05	CD	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
reject	reject	VBP	0
the	the	DT	0
null	null	JJ	0
hypothesis	hypothesis	NN	0
at	at	IN	0
the	the	DT	0
α	α	JJ	0
level	level	NN	0
of	of	IN	0
significance	significance	NN	0
.	.	.	0
Working	Working	VBG	0
example	example	NN	0
We	We	PRP	0
analyze	analyze	VBP	0
the	the	DT	0
following	following	JJ	0
scenario	scenario	NN	0
as	as	IN	0
a	a	DT	0
working	working	JJ	0
example	example	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Additional	Additional	JJ	0
file	file	NN	0
1	1	CD	0
Click	Click	NNS	0
here	here	RB	0
for	for	IN	0
file	file	JJ	0
Additional	Additional	JJ	0
file	file	NN	0
2	2	CD	0
Click	Click	NNS	0
here	here	RB	0
for	for	IN	0
file	file	JJ	0
Additional	Additional	JJ	0
file	file	NN	0
3	3	CD	0
Click	Click	NNS	0
here	here	RB	0
for	for	IN	0
file	file	VB	0
The	The	DT	0
consensus	consensus	NN	0
codon	codon	NN	0
is	is	VBZ	0
given	given	VBN	0
as	as	IN	0
ttt	ttt	NNS	0
(	(	-LRB-	0
Phe	Phe	NNP	0
;	;	:	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
column	column	NN	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Each	Each	DT	0
observed	observed	JJ	0
mutation	mutation	NN	0
is	is	VBZ	0
also	also	RB	0
given	given	VBN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
columns	columns	CD	0
1-3	1-3	CD	0
)	)	-RRB-	0
Because	Because	IN	0
we	we	PRP	0
know	know	VBP	0
the	the	DT	0
frequency	frequency	NN	0
of	of	IN	0
silent	silent	JJ	0
mutations	mutations	NNS	0
(	(	-LRB-	0
given	given	VBN	0
as	as	IN	0
10	10	CD	0
in	in	IN	0
this	this	DT	0
example	example	NN	0
;	;	:	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
column	column	NN	0
3	3	LS	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
also	also	RB	0
know	know	VB	0
the	the	DT	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
for	for	IN	0
each	each	DT	0
replacement	replacement	NN	0
mutation	mutation	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
column	column	NN	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
That	That	WDT	0
is	is	VBZ	0
,	,	,	0
if	if	IN	0
selection	selection	NN	0
is	is	VBZ	0
neutral	neutral	JJ	0
for	for	IN	0
any	any	DT	0
particular	particular	JJ	0
replacement	replacement	NN	0
mutation	mutation	NN	0
,	,	,	0
we	we	PRP	0
can	can	MD	0
calculate	calculate	VB	0
the	the	DT	0
incidence	incidence	NN	0
of	of	IN	0
each	each	DT	0
replacement	replacement	NN	0
mutation	mutation	VBD	0
we	we	PRP	0
expect	expect	VBP	0
to	to	TO	0
observe	observe	VB	0
(	(	-LRB-	0
by	by	IN	0
looking	looking	VBG	0
at	at	IN	0
a	a	DT	0
table	table	NN	0
of	of	IN	0
the	the	DT	0
genetic	genetic	JJ	0
code	code	NN	0
)	)	-RRB-	0
.	.	.	0
Using	Using	VBG	0
the	the	DT	0
given	given	VBN	0
frequency	frequency	NN	0
of	of	IN	0
each	each	DT	0
mutation	mutation	NN	0
observed	observed	VBD	0
,	,	,	0
we	we	PRP	0
also	also	RB	0
know	know	VB	0
what	what	WP	0
the	the	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
in	in	IN	0
each	each	DT	0
case	case	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
column	column	NN	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Now	Now	RB	0
we	we	PRP	0
use	use	VBP	0
a	a	DT	0
two-tailed	two-tailed	JJ	0
test	test	NN	0
of	of	IN	0
the	the	DT	0
binomial	binomial	JJ	B-NP
distribution	distribution	NN	I-NP
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
each	each	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
significantly	significantly	RB	0
different	different	JJ	0
from	from	IN	0
the	the	DT	0
corresponding	corresponding	JJ	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
,	,	,	0
column	column	NN	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
some	some	DT	0
cases	cases	NNS	0
,	,	,	0
the	the	DT	0
differences	differences	NNS	0
are	are	VBP	0
significant	significant	JJ	0
,	,	,	0
in	in	IN	0
which	which	WDT	0
case	case	NN	0
the	the	DT	0
appropriate	appropriate	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
is	is	VBZ	0
assigned	assigned	VBN	0
positive	positive	JJ	0
or	or	CC	0
negative	negative	JJ	B-NP
selection	selection	NN	I-NP
(	(	-LRB-	0
positive	positive	JJ	0
if	if	IN	0
the	the	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
larger	larger	JJR	0
than	than	IN	0
expected	expected	VBN	0
and	and	CC	0
negative	negative	JJ	0
if	if	IN	0
the	the	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
lower	lower	JJR	0
than	than	IN	0
expected	expected	VBN	0
)	)	-RRB-	0
.	.	.	0
Otherwise	Otherwise	RB	0
,	,	,	0
the	the	DT	0
selection	selection	NN	0
is	is	VBZ	0
assigned	assigned	VBN	0
to	to	TO	0
be	be	VB	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
.	.	.	0
The	The	DT	0
QUASI	QUASI	NNP	B-NP
algorithm	algorithm	VBD	0
thus	thus	RB	0
indicates	indicates	VBZ	0
at	at	IN	0
this	this	DT	0
exemplary	exemplary	JJ	B-NP
codon	codon	NN	I-NP
that	that	IN	0
both	both	DT	0
tyrosine	tyrosine	NN	B-NP
and	and	CC	0
serina	serina	NN	B-NP
are	are	VBP	0
positively	positively	RB	0
selected	selected	VBN	0
;	;	:	0
isoleucine	isoleucine	CD	B-NP
,	,	,	0
leucine	leucine	NN	B-NP
,	,	,	0
and	and	CC	0
cystina	cystina	NN	B-NP
are	are	VBP	0
negatively	negatively	RB	0
selected	selected	VBN	0
;	;	:	0
and	and	CC	0
the	the	DT	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
or	or	CC	0
valine	valine	NN	B-NP
disadvantage	disadvantage	NN	I-NP
is	is	VBZ	0
indistinguishable	indistinguishable	VBN	0
from	from	IN	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
.	.	.	0
Any	Any	DT	0
other	other	JJ	0
ttt	ttt	JJ	B-NP
codon	codon	NN	I-NP
will	will	MD	0
have	have	VB	0
its	its	PRP$	0
own	own	JJ	0
selective	selective	JJ	B-NP
pressure	pressure	NN	I-NP
assessed	assessed	VBN	0
in	in	IN	0
a	a	DT	0
similar	similar	JJ	0
but	but	CC	0
independent	independent	JJ	0
testing	testing	NN	B-NP
procedure	procedure	NN	I-NP
.	.	.	0
minimum	minimum	JJ	B-NP
sequence	sequence	NN	I-NP
For	For	IN	0
each	each	DT	0
possible	possible	JJ	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
,	,	,	0
a	a	DT	0
minimum	minimum	JJ	0
number	number	NN	0
of	of	IN	0
mutations	mutations	NNS	0
will	will	MD	0
need	need	VB	0
to	to	TO	0
be	be	VB	0
observed	observed	VBN	0
for	for	IN	0
a	a	DT	0
selective	selective	JJ	B-NP
event	event	NN	I-NP
to	to	TO	0
be	be	VB	0
detected	detected	VBN	0
.	.	.	0
This	This	DT	0
minimum	minimum	JJ	0
number	number	NN	0
differs	differs	VBZ	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
consensus	consensus	NN	B-NP
codon	codon	NN	I-NP
and	and	CC	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
significance	significance	NN	B-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
calculated	calculated	VBN	0
the	the	DT	0
minimum	minimum	JJ	0
number	number	NN	0
of	of	IN	0
mutations	mutations	NNS	0
needed	needed	VBN	0
to	to	TO	0
achieve	achieve	VB	0
the	the	DT	0
5	5	CD	0
%	%	NN	0
significance	significance	NN	B-NP
level	level	NN	I-NP
.	.	.	0
At	At	IN	0
the	the	DT	0
lower	lower	JJR	0
bound	bound	NN	0
of	of	IN	0
this	this	DT	0
range	range	NN	0
,	,	,	0
only	only	RB	0
2	2	CD	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
will	will	MD	0
be	be	VB	0
required	required	VBN	0
to	to	TO	0
detect	detect	VB	0
positive	positive	JJ	B-NP
selection	selection	NN	I-NP
for	for	IN	0
any	any	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
from	from	IN	0
cta	cta	NN	B-NP
or	or	CC	0
ctg	ctg	NN	B-NP
.	.	.	0
Any	Any	DT	0
replacement	replacement	NN	B-NP
mutation	mutation	NN	I-NP
from	from	IN	0
cta	cta	NN	B-NP
or	or	CC	0
ctg	ctg	NN	B-NP
has	has	VBZ	0
an	an	DT	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
1	1	CD	0
:	:	:	0
4	4	CD	0
,	,	,	0
and	and	CC	0
thus	thus	RB	0
an	an	DT	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
of	of	IN	0
2	2	CD	0
:	:	:	0
0	0	CD	0
will	will	MD	0
be	be	VB	0
sufficient	sufficient	JJ	0
to	to	TO	0
reject	reject	VB	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
in	in	IN	0
favor	favor	NN	0
of	of	IN	0
positive	positive	JJ	B-NP
selection	selection	NN	I-NP
.	.	.	0
Conversely	Conversely	RB	0
,	,	,	0
detecting	detecting	VBG	0
negative	negative	JJ	B-NP
selection	selection	NN	I-NP
at	at	IN	0
a	a	DT	0
cta	cta	NN	B-NP
or	or	CC	0
ctg	ctg	JJ	B-NP
codon	codon	NN	I-NP
is	is	VBZ	0
difficult	difficult	JJ	0
.	.	.	0
At	At	IN	0
the	the	DT	0
upper	upper	JJ	0
bound	bound	NN	0
of	of	IN	0
the	the	DT	0
range	range	NN	0
,	,	,	0
a	a	DT	0
minimum	minimum	NN	0
of	of	IN	0
17	17	CD	0
observed	observed	JJ	0
mutations	mutations	NNS	0
are	are	VBP	0
required	required	VBN	0
to	to	TO	0
detect	detect	VB	0
negative	negative	JJ	B-NP
selection	selection	NN	I-NP
at	at	IN	0
such	such	PDT	0
a	a	DT	0
codon	codon	NN	B-NP
(	(	-LRB-	0
0	0	CD	0
:	:	:	0
17	17	CD	0
is	is	VBZ	0
significantly	significantly	RB	0
lower	lower	JJR	0
than	than	IN	0
1	1	CD	0
:	:	:	0
4	4	LS	0
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
the	the	DT	0
most-typical	most-typical	JJ	B-NP
codon	codon	NN	I-NP
,	,	,	0
the	the	DT	0
expected	expected	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
is	is	VBZ	0
1	1	CD	0
:	:	:	0
3	3	LS	0
.	.	.	0
For	For	IN	0
these	these	DT	0
modal	modal	JJ	B-NP
codon	codon	NN	I-NP
,	,	,	0
at	at	IN	0
least	least	JJS	0
3	3	CD	0
mutations	mutations	NNS	0
must	must	MD	0
be	be	VB	0
observed	observed	VBN	0
to	to	TO	0
detect	detect	VB	0
positive	positive	JJ	B-NP
selection	selection	NN	I-NP
(	(	-LRB-	0
i.e.	i.e.	FW	0
,	,	,	0
if	if	IN	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
=	=	SYM	0
3	3	CD	0
:	:	:	0
0	0	CD	0
)	)	-RRB-	0
.	.	.	0
At	At	IN	0
the	the	DT	0
same	same	JJ	0
most-typical	most-typical	JJ	B-NP
codon	codon	NN	I-NP
,	,	,	0
12	12	CD	0
mutations	mutations	NNS	0
are	are	VBP	0
required	required	VBN	0
,	,	,	0
at	at	IN	0
a	a	DT	0
minimum	minimum	NN	0
,	,	,	0
to	to	TO	0
detect	detect	VB	0
negative	negative	JJ	B-NP
selection	selection	NN	I-NP
(	(	-LRB-	0
i.e.	i.e.	FW	0
,	,	,	0
if	if	IN	0
observed	observed	JJ	0
R	R	NN	0
:	:	:	0
S	S	NNP	0
=	=	SYM	0
0	0	CD	0
:	:	:	0
12	12	CD	0
)	)	-RRB-	0
.	.	.	0
Because	Because	IN	0
positive	positive	JJ	B-NP
selection	selection	NN	I-NP
identification	identification	NN	I-NP
is	is	VBZ	0
generally	generally	RB	0
the	the	DT	0
goal	goal	NN	0
,	,	,	0
the	the	DT	0
QUASI	QUASI	NNP	B-NP
algorithm	algorithm	NN	I-NP
appears	appears	VBZ	0
to	to	TO	0
have	have	VB	0
a	a	DT	0
practical	practical	JJ	B-NP
advantage	advantage	NN	I-NP
over	over	IN	0
extant	extant	JJ	0
selection	selection	NN	B-NP
detector	detector	NN	I-NP
,	,	,	0
which	which	WDT	0
require	require	VBP	0
either	either	RB	0
many	many	JJ	0
more	more	JJR	0
mutations	mutations	NNS	0
or	or	CC	0
a	a	DT	0
biased	biased	JJ	0
expectation	expectation	NN	0
of	of	IN	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
in	in	IN	0
order	order	NN	0
to	to	TO	0
detect	detect	VB	0
positive	positive	JJ	B-NP
selection	selection	NN	I-NP
.	.	.	0
False-positive	False-positive	JJ	B-NP
testing	testing	NN	I-NP
False	False	NNP	0
positives	positives	NNS	0
are	are	VBP	0
likeliest	likeliest	VBN	0
when	when	WRB	0
drift	drift	NN	0
is	is	VBZ	0
completely	completely	RB	0
neutral	neutral	JJ	0
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
as	as	RB	0
was	was	VBD	0
found	found	VBN	0
by	by	IN	0
Suzuki	Suzuki	NNP	0
and	and	CC	0
Gojobori	Gojobori	NNP	B-NP
[	[	-LRB-	0
36	36	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
One	One	PRP	0
may	may	MD	0
estimate	estimate	VB	0
the	the	DT	0
maximum	maximum	JJ	0
frequency	frequency	NN	0
of	of	IN	0
false	false	JJ	0
positives	positives	NN	0
by	by	IN	0
testing	testing	VBG	0
simulated	simulated	NNS	0
sequences	sequences	VBP	0
generated	generated	VBN	0
under	under	IN	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
parameter	parameter	NN	I-NP
.	.	.	0
We	We	PRP	0
used	used	VBD	0
the	the	DT	0
paml	paml	NN	B-NP
package	package	NN	I-NP
evolver	evolver	NN	I-NP
program	program	NN	I-NP
[	[	-LRB-	0
54	54	CD	0
]	]	-RRB-	0
to	to	TO	0
generate	generate	VB	0
sequences	sequences	JJ	0
drifting	drifting	NN	0
under	under	IN	0
neutral	neutral	JJ	B-NP
Jukes-Cantor	Jukes-Cantor	JJ	I-NP
evolution	evolution	NN	I-NP
.	.	.	0
For	For	IN	0
each	each	DT	0
simulation	simulation	NN	0
,	,	,	0
we	we	PRP	0
generated	generated	VBD	0
300	300	CD	0
related	related	JJ	0
sequences	sequences	NN	0
of	of	IN	0
length	length	NN	0
999	999	CD	0
and	and	CC	0
with	with	IN	0
average	average	JJ	0
branch	branch	NN	0
lengths	lengths	NNS	0
varying	varying	VBG	0
in	in	IN	0
0.1	0.1	CD	0
length	length	NN	B-NP
interval	interval	NN	I-NP
from	from	IN	0
0.1	0.1	CD	0
to	to	TO	0
1.0	1.0	CD	0
;	;	:	0
each	each	DT	0
parameter	parameter	JJ	B-NP
set	set	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
generate	generate	VB	0
10	10	CD	0
sets	sets	NNS	0
of	of	IN	0
300	300	CD	0
sequences	sequences	NNS	0
.	.	.	0
false	false	JJ	B-NP
positive	positive	JJ	I-NP
percentage	percentage	NN	I-NP
[	[	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
;	;	:	0
false	false	JJ	0
positive	positive	JJ	B-NP
percentage	percentage	NN	I-NP
=	=	SYM	0
false	false	FW	0
positives	positives	FW	0
/	/	FW	0
(	(	-LRB-	0
false	false	FW	0
positives	positives	FW	0
+	+	FW	0
neutral	neutral	FW	0
drift	drift	FW	0
variants	variants	FW	0
)	)	-RRB-	0
]	]	-RRB-	0
were	were	VBD	0
extremely	extremely	RB	0
low	low	JJ	0
(	(	-LRB-	0
∼	∼	CD	0
2	2	CD	0
%	%	NN	0
)	)	-RRB-	0
for	for	IN	0
relatively	relatively	RB	0
long	long	JJ	0
branch	branch	NN	0
lengths	lengths	NNS	0
(	(	-LRB-	0
0.1-1.0	0.1-1.0	NNP	0
)	)	-RRB-	0
.	.	.	0
Extremely	Extremely	RB	0
high	high	JJ	0
false	false	JJ	0
positive	positive	JJ	B-NP
rate	rate	NN	I-NP
(	(	-LRB-	0
up	up	RB	0
to	to	TO	0
70	70	CD	0
%	%	NN	0
)	)	-RRB-	0
were	were	VBD	0
found	found	VBN	0
for	for	IN	0
extremely	extremely	RB	0
short	short	JJ	0
branch	branch	NN	0
lengths	lengths	NNS	0
(	(	-LRB-	0
maximum	maximum	NN	B-NP
at	at	IN	0
0.001	0.001	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	IN	0
accurate	accurate	JJ	0
branch	branch	NN	0
lengths	lengths	NNS	0
are	are	VBP	0
calculated	calculated	VBN	0
using	using	VBG	0
maximum	maximum	JJ	0
likelihood	likelihood	NN	B-NP
phylogeny	phylogeny	NN	I-NP
,	,	,	0
these	these	DT	0
branch	branch	NN	0
lengths	lengths	NNS	0
may	may	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
find	find	VB	0
the	the	DT	0
appropriate	appropriate	JJ	0
false-positive	false-positive	JJ	B-NP
percentage	percentage	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
if	if	IN	0
the	the	DT	0
branch	branch	NN	0
length	length	NN	0
were	were	VBD	0
0.01	0.01	CD	0
[	[	-LRB-	0
as	as	RB	0
appears	appears	VBZ	0
appropriate	appropriate	JJ	0
for	for	IN	0
hemagglutinin	hemagglutinin	NN	B-NP
(	(	-LRB-	0
unpublished	unpublished	JJ	0
observation	observation	NN	0
)	)	-RRB-	0
]	]	-RRB-	0
,	,	,	0
then	then	RB	0
the	the	DT	0
maximum	maximum	JJ	0
false	false	JJ	0
positive	positive	JJ	B-NP
rate	rate	NN	I-NP
would	would	MD	0
be	be	VB	0
estimated	estimated	VBN	0
at	at	IN	0
32	32	CD	0
%	%	NN	0
.	.	.	0
We	We	PRP	0
then	then	RB	0
use	use	VB	0
the	the	DT	0
calculated	calculated	JJ	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
frequency	frequency	NN	I-NP
(	(	-LRB-	0
from	from	IN	0
QUASI	QUASI	NNP	B-NP
)	)	-RRB-	0
as	as	IN	0
an	an	DT	0
estimator	estimator	NN	B-NP
for	for	IN	0
the	the	DT	0
maximum	maximum	JJ	0
false	false	JJ	0
positives	positives	NN	0
.	.	.	0
If	If	IN	0
(	(	-LRB-	0
as	as	IN	0
we	we	PRP	0
report	report	VBP	0
)	)	-RRB-	0
hemagglutinin	hemagglutinin	NN	B-NP
is	is	VBZ	0
found	found	VBN	0
to	to	TO	0
have	have	VB	0
5	5	CD	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
variant	variant	JJ	I-NP
,	,	,	0
then	then	RB	0
we	we	PRP	0
would	would	MD	0
expect	expect	VB	0
a	a	DT	0
maximum	maximum	NN	B-NP
of	of	IN	0
2.3	2.3	CD	0
false-positive	false-positive	NN	B-NP
.	.	.	0
Selection	Selection	NN	0
mapping	mapping	NN	0
QUASI	QUASI	NNP	0
presents	presents	VBZ	0
its	its	PRP$	0
results	results	NNS	0
in	in	IN	0
the	the	DT	0
following	following	JJ	0
format	format	NN	0
:	:	:	0
1	1	LS	0
.	.	.	0
The	The	DT	0
consensus	consensus	NN	0
amino	amino	NN	0
acids	acids	NNS	0
are	are	VBP	0
written	written	VBN	0
in	in	IN	0
capital	capital	NN	0
letters.	letters.	CD	0
2	2	CD	0
.	.	.	0
Beneath	Beneath	IN	0
each	each	DT	0
consensus	consensus	NN	0
amino	amino	NN	0
acid	acid	NN	B-NP
are	are	VBP	0
written	written	VBN	0
in	in	IN	0
capital	capital	NN	0
letters	letters	NNS	0
all	all	DT	0
variants	variants	NN	0
determined	determined	VBN	0
to	to	TO	0
be	be	VB	0
positively	positively	RB	0
selected	selected	VBN	0
(	(	-LRB-	0
in	in	IN	0
descending	descending	VBG	B-NP
order	order	NN	I-NP
of	of	IN	0
frequency	frequency	NN	0
)	)	-RRB-	0
.	.	.	0
3	3	LS	0
.	.	.	0
The	The	DT	0
negatively	negatively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
not	not	RB	0
shown.	shown.	CD	0
4	4	CD	0
.	.	.	0
In	In	IN	0
lowercase	lowercase	JJ	B-NP
letter	letter	NN	I-NP
and	and	CC	0
interspersed	interspersed	VBN	0
according	according	VBG	0
to	to	TO	0
their	their	PRP$	0
frequencies	frequencies	NN	0
among	among	IN	0
the	the	DT	0
positively	positively	RB	0
selected	selected	VBN	B-NP
variant	variant	JJ	I-NP
are	are	VBP	0
variants	variants	VBN	0
where	where	WRB	0
the	the	DT	0
neutral	neutral	JJ	B-NP
drift	drift	NN	I-NP
null	null	NNS	0
hypothesis	hypothesis	VBP	0
cannot	cannot	RB	0
be	be	VB	0
rejected	rejected	VBN	0
with	with	IN	0
the	the	DT	0
given	given	VBN	0
sequence	sequence	JJ	0
data	data	NNS	0
.	.	.	0
As	As	IN	0
a	a	DT	0
reasonable	reasonable	JJ	0
but	but	CC	0
arbitrary	arbitrary	JJ	0
cut-off	cut-off	NN	0
,	,	,	0
we	we	PRP	0
include	include	VBP	0
apparently	apparently	RB	0
unselected	unselected	JJ	0
variants	variants	NN	0
if	if	IN	0
they	they	PRP	0
are	are	VBP	0
among	among	IN	0
the	the	DT	0
2	2	CD	0
H+σmost	H+σmost	CD	0
frequent	frequent	JJ	0
variants	variants	NN	0
,	,	,	0
where	where	WRB	0
H	H	NNP	0
is	is	VBZ	0
the	the	DT	0
Shannon	Shannon	NNP	B-NP
information	information	NN	I-NP
content	content	NN	I-NP
of	of	IN	0
the	the	DT	0
site	site	NN	0
and	and	CC	0
σ	σ	NN	0
is	is	VBZ	0
the	the	DT	0
standard	standard	JJ	0
error	error	NN	0
of	of	IN	0
its	its	PRP$	0
estimation	estimation	NNS	0
[	[	-LRB-	0
55	55	CD	0
]	]	-RRB-	0
.	.	.	0
is	is	VBZ	0
the	the	DT	0
i	i	JJ	B-NP
th	th	JJ	I-NP
fraction	fraction	NN	I-NP
of	of	IN	0
amino	amino	JJ	0
acids	acids	NNS	0
at	at	IN	0
the	the	DT	0
site	site	NN	0
(	(	-LRB-	0
the	the	DT	0
alignment	alignment	JJ	B-NP
gap	gap	NN	I-NP
is	is	VBZ	0
counted	counted	VBN	0
as	as	IN	0
a	a	DT	0
21st	21st	JJ	0
amino	amino	JJ	0
acid	acid	NN	0
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
the	the	DT	0
Shannon	Shannon	NNP	B-NP
calculation	calculation	NN	I-NP
,	,	,	0
alignment	alignment	JJ	B-NP
gap	gap	NN	I-NP
are	are	VBP	0
considered	considered	VBN	0
distinct	distinct	JJ	0
from	from	IN	0
"no	"no	CD	0
data	data	NNS	0
"	"	``	0
gaps	gaps	FW	0
(	(	-LRB-	0
artifacts	artifacts	NN	0
of	of	IN	0
indeterminate	indeterminate	JJ	0
sequencing	sequencing	NN	B-NP
or	or	CC	0
sequence	sequence	JJ	0
fragment	fragment	NN	0
overlaps	overlaps	NNS	0
;	;	:	0
such	such	JJ	0
data	data	NN	0
absences	absences	NNS	0
are	are	VBP	0
excluded	excluded	VBN	0
from	from	IN	0
calculation	calculation	NN	0
)	)	-RRB-	0
.	.	.	0
Sequences	Sequences	NNP	0
nucleotide	nucleotide	NN	B-NP
sequence	sequence	NN	I-NP
were	were	VBD	0
downloaded	downloaded	VBN	0
from	from	IN	0
GenBank	GenBank	JJ	0
at	at	IN	0
the	the	DT	0
NIH	NIH	NNP	B-NP
.	.	.	0
Sequences	Sequences	NNP	0
were	were	VBD	0
included	included	VBN	0
only	only	RB	0
if	if	IN	0
they	they	PRP	0
were	were	VBD	0
isolated	isolated	VBN	0
in	in	IN	0
the	the	DT	0
field	field	NN	0
and	and	CC	0
were	were	VBD	0
not	not	RB	0
obviously	obviously	RB	0
pseudogenes	pseudogenes	JJ	0
(	(	-LRB-	0
sequences	sequences	VBN	0
containing	containing	VBG	0
premature	premature	JJ	0
stop	stop	NN	B-NP
codon	codon	NN	I-NP
were	were	VBD	0
removed	removed	VBN	0
from	from	IN	0
consideration	consideration	NN	B-NP
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
analyzed	analyzed	VBD	0
310	310	CD	0
sequences	sequences	NN	0
of	of	IN	0
human-infective	human-infective	JJ	B-NP
influenza	influenza	NN	I-NP
A	A	DT	0
(	(	-LRB-	0
H3	H3	NN	B-NP
serotype	serotype	NN	I-NP
)	)	-RRB-	0
,	,	,	0
6,151	6,151	NNP	0
hiv-1	hiv-1	NN	B-NP
gp120	gp120	NNP	I-NP
sequence	sequence	NN	I-NP
,	,	,	0
and	and	CC	0
400	400	CD	0
hiv-1	hiv-1	NN	B-NP
rt	rt	NN	I-NP
sequence	sequence	NN	I-NP
.	.	.	0
All	All	DT	0
sequences	sequences	NN	0
were	were	VBD	0
pre-aligned	pre-aligned	JJ	B-NP
with	with	IN	0
PILEUP	PILEUP	NNP	B-NP
[	[	-LRB-	0
56	56	CD	0
]	]	-RRB-	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
DIALIGN2	DIALIGN2	NNP	B-NP
[	[	-LRB-	0
57	57	CD	0
]	]	-RRB-	0
then	then	RB	0
hand-corrected	hand-corrected	JJ	0
.	.	.	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
abbreviation	abbreviation	NN	I-NP
,	,	,	0
human	human	JJ	0
immunodeficiency	immunodeficiency	JJ	B-NP
virus	virus	NN	I-NP
;	;	:	0
hemagglutinin	hemagglutinin	NN	B-NP
,	,	,	0
hemagglutinin	hemagglutinin	NN	B-NP
;	;	:	0
Ab	Ab	NNP	B-NP
,	,	,	0
antibody	antibody	NN	B-NP
;	;	:	0
gp120	gp120	CD	B-NP
,	,	,	0
glycoprotein	glycoprotein	CD	B-NP
120	120	CD	0
;	;	:	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
,	,	,	0
reverse	reverse	JJ	B-NP
transcriptase	transcriptase	NN	I-NP
;	;	:	0
R	R	NNP	0
:	:	:	0
S	S	NNP	0
,	,	,	0
replacement	replacement	NN	0
to	to	TO	0
silent	silent	JJ	0
mutation	mutation	NN	B-NP
ratio	ratio	NN	I-NP
;	;	:	0
CD4BS	CD4BS	CD	0
,	,	,	0
CD4	CD4	CD	B-NP
binding	binding	JJ	0
site	site	NN	B-NP
epitopa	epitopa	NN	I-NP
;	;	:	0
CD4i	CD4i	CD	0
,	,	,	0
CD4-induced	CD4-induced	CD	B-NP
epitopa	epitopa	NN	I-NP
;	;	:	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
complex	complex	JJ	I-NP
,	,	,	0
major	major	JJ	0
histocompatibility	histocompatibility	JJ	B-NP
complex	complex	NN	I-NP
;	;	:	0
AZT	AZT	NNP	B-NP
,	,	,	0
3	3	CD	0
'	'	POS	B-NP
-azido-3	-azido-3	NNP	I-NP
'	'	POS	I-NP
-deoxythymidine	-deoxythymidine	JJ	I-NP
.	.	.	0
